2025 Annual Meeting | P8 - Poster Session 08

Date Tuesday 04/08/25

Time 08:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | Exhibit Hall A

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Headache, Movement Disorders, Neuro-oncology, Sleep, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Infectious Disease, ��ɫ��, Research, and Methodology, Autoimmune Neurology, Neuro Trauma and Critical Care

Learning Objectives View the latest research on a variety of topics. Posters are available to view in-person or online.

CME Available 0.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Interactive

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM PDT	Abstract	1-001 - Equitable Implementation of Highly Efficacious Treatments for Multiple Sclerosis Annette M. Langer-Gould, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	1-002 - Multiple Sclerosis in the Emergency Department: A Retrospective Case-control Study in a Large U.S. Center Siddharth Satish, Student
08:00 AM - 09:00 AM PDT	Abstract	1-003 - Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile from the OCARINA II Study and Patient Preferences Scott D. Newsome, DO, FAAN
08:00 AM - 09:00 AM PDT	Abstract	1-004 - Neutropenia and Neutropenic Fever in Patients with Multiple Sclerosis on B-cell Depleting Therapies Matthew Doerfler, MD
08:00 AM - 09:00 AM PDT	Abstract	1-005 - Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension Jiwon Oh, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	1-006 - Enhanced Safety Profile of Ocrelizumab Over Rituximab in Multiple Sclerosis Treatment Gabriel A. Cerono
08:00 AM - 09:00 AM PDT	Abstract	1-008 - Comparison of B-cell Depletion and Natalizumab for Treatment of Multiple Sclerosis: A Semi-supervised Causal Analysis James D. DiSanto, MSc
08:00 AM - 09:00 AM PDT	Abstract	1-009 - From Trials to Real-world Data: National Insights on Cladribine Tablets in Multiple Sclerosis After Four Years and Beyond Dominika Stastna, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	1-010 - Real-world Treatment Outcomes in People with Multiple Sclerosis Switched from Platform MS Treatments to Fumarates Versus Other Oral Disease-modifying Therapies Jose Avila-Ornelas, MD
08:00 AM - 09:00 AM PDT	Abstract	1-011 - Risk of Progression Independent of Relapse Activity and Disability Accumulation in a Real-world Cohort of Multiple Sclerosis Patients Initiated on High-efficacy Versus Low-efficacy Disease Modifying Therapy Jessica Ye, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	1-012 - Idiosyncratic Drug–induced Neutropenia Secondary to Ofatumumab Exposure in Multiple Sclerosis: A Case Report and Analysis of Food and Drug Administration Adverse Event Reporting System Rasika R. Viswanathan, MD
08:00 AM - 09:00 AM PDT	Abstract	1-013 - Risk of Hypogammaglobulinemia and Infections Associated with Rituximab Therapy in Patients with Multiple Sclerosis: A Systematic Review and Meta-analysis Barbara Antonia D. Talah, Medical Student
08:00 AM - 09:00 AM PDT	Abstract	1-014 - Colitis in Multiple Sclerosis Patients Treated with B-cell Depleting Monoclonal Antibodies Roberto Bomprezzi, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	1-015 - Severe Neutropenia Secondary to Ocrelizumab: Risk Factors Juan Joaquín Bermejillo Barrera, MD
08:00 AM - 09:00 AM PDT	Abstract	1-016 - Clinical Characteristics and Treatment Outcomes in Anti-CD20-treated Multiple Sclerosis Patients Who Switch to Natalizumab: A Komodo Health Sentinel Database Study Jonathan C. Calkwood, MD
08:00 AM - 09:00 AM PDT	Abstract	1-017 - Long-term Ofatumumab Treatment Over 6 Years Did Not Increase the Risk of Serious Infections Ibolya Boer, MD
08:00 AM - 09:00 AM PDT	Abstract	2-003 - Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls Alejandro Salah, MD, PhD, MBA, MHA
08:00 AM - 09:00 AM PDT	Abstract	2-004 - Smartphone-Mediated At-Home Telespirometry Erect and Supine Slow Vital Capacity Decline Differences Based On NIV Status in Subjects With ALS Eufrosina I. Young, MD
08:00 AM - 09:00 AM PDT	Abstract	2-005 - Development of a Tool for Community Deployment That Detects ALS and Other Neurodegenerative Diseases Priya Nigam, MD
08:00 AM - 09:00 AM PDT	Abstract	2-006 - Smartphone–Mediated, At-Home Telespirometry Vital Capacity (VC) Measurements in ALS: Point-of-Care Quality Assessment for Slow VC and Forced VC George P. Slavinski, Respiratory Therapist
08:00 AM - 09:00 AM PDT	Abstract	2-007 - Amyotrophic Lateral Sclerosis at Geisinger Medical Center: Disease-Modifying Treatment and Advanced Care Planning Anvi Kumar
08:00 AM - 09:00 AM PDT	Abstract	2-008 - Amyotrophic Lateral Sclerosis at Geisinger Medical Center: Patient Demographics and Clinical Characteristics Minali Tare
08:00 AM - 09:00 AM PDT	Abstract	2-009 - Referral Patterns for Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database Malgorzata Ciepielewska
08:00 AM - 09:00 AM PDT	Abstract	2-010 - Application of a Clinical Algorithm on Real-World Electronic Medical Record Data to Assist With Earlier Detection of Amyotrophic Lateral Sclerosis Amanda E. Fiander, MD
08:00 AM - 09:00 AM PDT	Abstract	2-011 - Food Effect Study of Fosigotifator, an eIF2B Activator being developed as a Potential Treatment for Amyotrophic Lateral Sclerosis, Vanishing White Matter Disease, and Major Depressive Disorder Matthew Rosebraugh, PhD
08:00 AM - 09:00 AM PDT	Abstract	2-012 - Treatment of Amyotrophic Lateral Sclerosis in General and Specialist US Healthcare Settings: Results From a Real-World Survey Malgorzata Ciepielewska
08:00 AM - 09:00 AM PDT	Abstract	3-001 - A Quality Improvement Initiative for Emergency Department Neuropsychiatric Symptom Management in Dementia Shari M. Duarte, MD
08:00 AM - 09:00 AM PDT	Abstract	3-004 - Efficacy of Pharmacological Interventions in Lewy Body Dementia: An Updated Systematic Review and Network Meta-Analysis Vinay Suresh, MBBS
08:00 AM - 09:00 AM PDT	Abstract	3-005 - Baseline Characteristics for INFRONT-3: A Phase 3 Double-Blind, Placebo-Controlled 96-Week Study Evaluating Latozinemab in FTD-GRN Tiffany W. Chow, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	3-006 - Biomarker-Guided Brain Stimulation for Memory Loss Haydn Herrema
08:00 AM - 09:00 AM PDT	Abstract	3-007 - Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species Johanne M. Kaplan, PhD
08:00 AM - 09:00 AM PDT	Abstract	3-008 - PERSEVERE: National Randomized Controlled Trial of Peer Mentor Support and Caregiver ��ɫ�� in Lewy Body Dementia. Jori Fleisher, MD, MSCE, FAAN
08:00 AM - 09:00 AM PDT	Abstract	3-009 - Episodic Simulation (ES) in Transient Global Amnesia (TGA) Jessica E. Decker, DO
08:00 AM - 09:00 AM PDT	Abstract	3-010 - Comparative Efficacy of BEAM EEG and MMSE in Early Detection of Mild Cognitive Impairment: A Pilot Study Janette Bow-Keola
08:00 AM - 09:00 AM PDT	Abstract	3-011 - Multifield Extended High-Definition Transcranial Direct Current Stimulation (MFE HD-tDCS) in Mild Cognitive Impairment (MCI): Effects on Cognition and Brain Network Connectivity. Abigail K. Peterson
08:00 AM - 09:00 AM PDT	Abstract	3-013 - Neuro-Exergaming for Mild Cognitive Impairment (MCI): Clinical Trial Findings from the Interactive Physical and Cognitive Exercise System (iPACES v3) Cay Anderson-Hanley, PhD
08:00 AM - 09:00 AM PDT	Abstract	3-015 - Matcha Green Tea on Cognitive Functions: A Systematic Review and Meta Analysis Julia Mello, Student
08:00 AM - 09:00 AM PDT	Abstract	3-016 - A First-in-Human Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3-Mediated Neuroinflammation Sagar Vaidya, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	3-017 - Effectiveness of Acetylcholinesterase Inhibitors for the Prevention and Treatment of Delirium in Hospitalized Patients: A Systematic Review and Meta-Analysis Leonardo Pipek, MD
08:00 AM - 09:00 AM PDT	Abstract	3-018 - Management of Minor Cognitive Impairment: A Worldwide Neurology Survey Graham A. McLeod, MD
08:00 AM - 09:00 AM PDT	Abstract	3-019 - Efficacy of Non Invasive Brain Stimulation Techniques in Depression: An Updated Systematic Review and Network Meta-Analysis Purani Jayaraj
08:00 AM - 09:00 AM PDT	Abstract	3-020 - Person-Centered Care and Trial Design for Progressive Supranuclear Palsy: A Collaborative Project of AFTD and CurePSP Shana Dodge
08:00 AM - 09:00 AM PDT	Abstract	4-001 - CRESCENDO: Results from a Survey of Symptom Burden and Quality of Life in Patients with Narcolepsy Type 1 Michael J. Thorpy, MD
08:00 AM - 09:00 AM PDT	Abstract	4-002 - Self-Reported Cognitive Complaints and Work Productivity in Participants With Narcolepsy or Idiopathic Hypersomnia After Low-Sodium Oxybate Treatment: Results From the Phase 4 DUET Study Logan D. Schneider, MD
08:00 AM - 09:00 AM PDT	Abstract	4-003 - Development of a Novel Patient-reported Outcome Measure of Functional Impacts for Narcolepsy Types 1 and 2 heather romero, PhD
08:00 AM - 09:00 AM PDT	Abstract	4-004 - The Orexin 2 Receptor Agonist ALKS 2680 in Patients with Narcolepsy Type 1: An Initial Proof of Concept Phase 1b Study Bhaskar Rege
08:00 AM - 09:00 AM PDT	Abstract	4-005 - Effects of Once-nightly Sodium Oxybate on Apnea-hypopnea Index: Post Hoc Analysis from the Phase 3 REST -ON Clinical Trial Natalie Batta, MD
08:00 AM - 09:00 AM PDT	Abstract	4-006 - Prevalence of Individuals with Pervasive Developmental Disorders living in Southern California that Have Sleep Disorders and/or Sleep Medication Prescriptions with Respect to Light Pollution at Night Deap S. Bhandal
08:00 AM - 09:00 AM PDT	Abstract	4-007 - Characterizing Sleep Disturbances in Long COVID: A Retrospective Analysis from a Safety Net Hospital Angela Sohng
08:00 AM - 09:00 AM PDT	Abstract	4-008 - Patient Preferences of Sodium Oxybate Treatment for Narcolepsy: RESTORE End-of-Study Survey Data Brian Abaluck, MD
08:00 AM - 09:00 AM PDT	Abstract	5-001 - @NMatch2025: The Expansion of a Student-Led Social Media-Based Initiative Guiding Adult Neurology and Child Neurology Residency Applicants in a Digital Era Roshini Chandrasekhar, MD
08:00 AM - 09:00 AM PDT	Abstract	5-002 - Understanding Disability and Adaptation of Patients and Physician Colleagues in Medicine: A Clerkship Curriculum Andrea Lendaris, MD, MS
08:00 AM - 09:00 AM PDT	Abstract	5-003 - Developing a Novel Disability-Focused Curriculum for Healthcare Professionals and Trainees through Web-based eLearning Modules Emily Eijansantos, MD
08:00 AM - 09:00 AM PDT	Abstract	5-004 - Medical Student Perspectives on Stigma in Functional Neurologic Disorder: A Qualitative Study Jordan Garris, MD
08:00 AM - 09:00 AM PDT	Abstract	5-005 - Developing Your Professional Self in 280 Characters or Less: a Qualitative Exploration of the Role of Social Media Engagement in Professional Identity Formation Among Neurology Trainees Gabriela Figueiredo Pucci, MD
08:00 AM - 09:00 AM PDT	Abstract	5-006 - Daily Knowledge, Stronger Results: Using the Neurology Question of the Day App to Boost Residency In-Service Training Exam Prep Jorge E. Patino Murillas, MD
08:00 AM - 09:00 AM PDT	Abstract	5-007 - Best Practices in Adult Outpatient Tele-Neurology: Literature Review James Grogan, MD
08:00 AM - 09:00 AM PDT	Abstract	5-008 - Best Practices in Adult Outpatient Tele-Neurology: Literature Review James Grogan, MD
08:00 AM - 09:00 AM PDT	Abstract	5-009 - Neurology ��ɫ�� in the Era of Teleneurology: Development and Evaluation of a Curriculum for Internal Medicine Residents at a Large Community Hospital without in-house Neurology Marinos G. Sotiropoulos, MD
08:00 AM - 09:00 AM PDT	Abstract	5-010 - The Use of an Artificial Intelligence-Based Communication Platform in Practicing Stroke-Related Patient Counseling for Neurology Residents Aimen Vanood, MD
08:00 AM - 09:00 AM PDT	Abstract	5-011 - AI-powered Translation In Neurology: Potential Gains and Ongoing Challenges For Use In The Clinic Michelle You
08:00 AM - 09:00 AM PDT	Abstract	5-012 - Double Agent AI: GPT as Virtual Patient and Tutor in Resident ��ɫ�� Jeffrey B. Ratliff, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	5-013 - The Future of Medical ��ɫ��: Assessing AI-Generated Podcast-like Reviews of Neurology Articles Brian J. Hanrahan, MD
08:00 AM - 09:00 AM PDT	Abstract	5-014 - Natural History of Gerstmann-Sträussler-Scheinker Syndrome in a Brazilian Cohort Marcos Vinicius Oliveira Marques, MD
08:00 AM - 09:00 AM PDT	Abstract	5-016 - Using 7-Tesla MRI as a Biomarker for CSF1R-related Disorders: Preliminary Results Tomasz Chmiela, MD
08:00 AM - 09:00 AM PDT	Abstract	5-017 - Evaluating the Utility of Biomarker in Assessing Symptoms of Patients with CSF1R-related Disorders Tomasz Chmiela, MD
08:00 AM - 09:00 AM PDT	Abstract	5-018 - Movement Disorders in Two Children with DNM1L-related Mitochondrial Cytopathy Manasa Sudheendra, MBBS
08:00 AM - 09:00 AM PDT	Abstract	5-019 - A Novel Variant of NBEA Causing Paroxysmal Kinesogenic Dyskinesia Manasa Sudheendra, MBBS
08:00 AM - 09:00 AM PDT	Abstract	5-020 - A Complex Phenotype in an Adult with Recurrent Syncope Dhruv Bansal, MBBS, MRCP UK
08:00 AM - 09:00 AM PDT	Abstract	5-021 - Decoding Destiny: The Genetic Puzzle of Adult-onset Alexander Disease Ramesh Shrestha, MD
08:00 AM - 09:00 AM PDT	Abstract	5-022 - The Neurological and Hepatic Nexus: Analyzing PFIC3 Presentation as Wilson Disease- Molecular Genetic Diagnosis and Treatment Response Jagjot Singh, MBBS
08:00 AM - 09:00 AM PDT	Abstract	5-023 - Illuminating the Presentation of Hereditary Spastic Paraplegia Type 7 (HSP7) Emma A. Snyder, MS, CGC (Genetic Counselor)
08:00 AM - 09:00 AM PDT	Abstract	5-024 - One Side of the Story: Unilateral Gyriform Enhancement in Wilson's Disease Nikita Srinivasan, MBBS
08:00 AM - 09:00 AM PDT	Abstract	5-025 - Bridging the Gap of CHD8-related Movement Disorders: Review of the Literature and a New Possible Case Due to a Novel Missense Variant Daniella Iglesias Hernández, MD
08:00 AM - 09:00 AM PDT	Abstract	5-026 - CSF Biomarkers in Hereditary Spastic Paraplegia: A Systematic Review Malavika Rudrakumar
08:00 AM - 09:00 AM PDT	Abstract	5-027 - Cannabidiol Intervention for Non-epileptic Myoclonus in Angelman Syndrome Cyrus Cheung
08:00 AM - 09:00 AM PDT	Abstract	5-028 - Jaw Clonus in Bulbar Onset Motor Neuron Disease Armando Martinez Salazar, MD
08:00 AM - 09:00 AM PDT	Abstract	5-029 - Acquired Hepatocerebral Degeneration: The Second Brain (HNS and CNS) Papul Chalia, MD
08:00 AM - 09:00 AM PDT	Abstract	5-030 - High Prevalence of Functional Neurologic Disorder in Fahr's Disease: A Case Series Zheming Yu, MD
08:00 AM - 09:00 AM PDT	Abstract	5-031 - Application of Subthalamic Nucleus as a Target for Deep Brain Stimulation in Pantothenate Kinase-associated Neurodegeneration Disease Sheida Koohsari, MD
08:00 AM - 09:00 AM PDT	Abstract	5-032 - Brain iron and calcium accumulation associated with generalized dystonia and Parkinsonism in a patient with mixed connective tissue disease - a case report Matheus Alves A. Silva, MD
08:00 AM - 09:00 AM PDT	Abstract	6-001 - Differential Diagnosis and Comparison of Diagnostic Algorithms in Children and Adolescents with Autoimmune Encephalitis Gemma Olivé, MD
08:00 AM - 09:00 AM PDT	Abstract	6-002 - ZSCAN1 Antibodies in Pediatric and Adult Patients With Non-Paraneoplastic ROHHAD Syndrome Gemma Olivé, MD
08:00 AM - 09:00 AM PDT	Abstract	6-003 - Prevalence and Outcomes of Pediatric Central Nervous System Infections: a Population-Based Analysis Andrej Roczkowsky
08:00 AM - 09:00 AM PDT	Abstract	6-004 - Obesity, Diet, & Physical Activity in Pediatric MS: Parental and Child Perceptions Emma L. Wetmore, MD
08:00 AM - 09:00 AM PDT	Abstract	6-005 - Pediatric Influenza-Related Acute Necrotizing Encephalopathy in the United States: A Multicenter Retrospective Analysis Andrew Silverman, MD
08:00 AM - 09:00 AM PDT	Abstract	6-006 - Novel Mechanism of Cerebral Folate Deficiency with Compound Heterozygous Variants in Reduced Folate Carrier (SLC19A1) in Two Siblings Manifesting with Acute Brainstem Lesions (Atypical ADEM) Sanjit K. Sah, MD
08:00 AM - 09:00 AM PDT	Abstract	6-007 - Superiority of Immunotherapy to Benzodiazepines and No Treatment in Down Syndrome Regression Disorder Shermila Pia, MD
08:00 AM - 09:00 AM PDT	Abstract	6-010 - Aberrant Somatic Hypermutation Plays Minor Role in the Evolution of Molecular Alterations at Recurrence in PCNSL Jennifer H. Newman, MD
08:00 AM - 09:00 AM PDT	Abstract	6-011 - Bing-Neel Syndrome: Lymphoplasmacytic Invasion of the Central Nervous System Nyle Almeida, MD
08:00 AM - 09:00 AM PDT	Abstract	6-012 - Froin’s Syndrome and Bilateral Choroid Plexitis Preceding the Diagnosis of Diffuse Large B-cell Lymphoma Melanie Li, MD
08:00 AM - 09:00 AM PDT	Abstract	6-013 - Neurological Presentation and Diagnosis of a Primary Central Nervous System ALK-positive Anaplastic Large Cell Lymphoma Riona Anvekar
08:00 AM - 09:00 AM PDT	Abstract	6-014 - Ibrutinib in Central Nervous System Lymphoma Jaber H. Jaradat, MD
08:00 AM - 09:00 AM PDT	Abstract	6-015 - Diffuse CNS Lymphoma Without Enhancement: A Case of Lymphomatosis Cerebri Shane Fuentes, MD
08:00 AM - 09:00 AM PDT	Abstract	6-016 - Clinical Characteristics of Primary T-cell Lymphoma of the Central Nervous System Hannah Padilla
08:00 AM - 09:00 AM PDT	Abstract	6-018 - Clinical, Radiological and Outcome Characteristics of Central Nervous System Lymphomatoid Granulomatosis Georg T. Scheffler, MD
08:00 AM - 09:00 AM PDT	Abstract	6-019 - Frosted Branch Angiitis as a Presenting Feature of Primary Central Nervous System Lymphoma Priyanka Atit, DO
08:00 AM - 09:00 AM PDT	Abstract	6-020 - Clinical Characteristics, Treatment Strategies, and Outcomes of Diffuse Large B-Cell Lymphoma Involving the Sciatic Nerve: A Systematic Review Kiran K. Sankarappan, BS
08:00 AM - 09:00 PM PDT	Abstract	7-001 - Andexanet Alfa Versus 4F-PCC for Direct Anticoagulation Reversal in Intracranial Hemorrhage: A Quality Improvement (QI) Analysis Audrey Huang
08:00 AM - 09:00 PM PDT	Abstract	7-002 - Accounting for Death in the Prediction of Post-intracerebral Hemorrhage Epilepsy Using Quantitative Electroencephalogram and Neuroimaging Justin R. Wheelock
08:00 AM - 09:00 PM PDT	Abstract	7-003 - Optimizing Intracerebral Hemorrhage Management and Interhospital Transfer with AI Driven Detection: Insights from Viz ICH Plus Ryan Afreen
08:00 AM - 09:00 PM PDT	Abstract	7-004 - The Role of Systemic Inflammatory Response Index (SIRI) in the Prognosis of Critically Ill Patients with Intracranial Hemorrhage Neha Sudarshan
08:00 AM - 09:00 PM PDT	Abstract	7-005 - Assessment of Optic Nerve Sheath Diameter in a Healthy Mexican Cohort Jimena Gonzalez Salido, MD
08:00 AM - 09:00 PM PDT	Abstract	7-007 - Delays in Diagnostic Neurological Testing for Acute Emergencies in Hospitalized Adults Karmveer Kaur
08:00 AM - 09:00 PM PDT	Abstract	7-008 - Disparities in Acute Neurological Care Access in Arizona: Addressing Barriers in Rural Versus Urban Regions Alyssa M. Kim
08:00 AM - 09:00 PM PDT	Abstract	7-009 - Ableist Language in Goals of Care Discussions in the Neurocritical Care Unit Winnie Liu
08:00 AM - 09:00 PM PDT	Abstract	7-010 - Harnessing Music Therapy in Neurocritical Care to Improve Patient Recovery and Physiological Stability Kerry Devlin, PhD
08:00 AM - 09:00 AM PDT	Abstract	8-001 - Exploring Triple Overlap Syndrome in Patients Receiving Immune Checkpoint Inhibitors: A Case Series Analysis Catherine Boldig, DO
08:00 AM - 09:00 AM PDT	Abstract	8-002 - Autoimmune Hematologic Complication of Immune Checkpoint Inhibition Treatment in a Case of Progressive Multifocal Leukoencephalopathy Thomas W. Johnson, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	8-003 - Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review tomohide ando, MD
08:00 AM - 09:00 AM PDT	Abstract	8-004 - Adalimumab Induced CNS Vasculitis Presenting as Cerebellar Ataxia Yelizaveta Lysakova, MD
08:00 AM - 09:00 AM PDT	Abstract	8-005 - Longitudinally-Extensive Transverse Myelitis After Introduction of IL-17 Monoclonal Antibody: A Case Report Heitor Cabral Frade, MD
08:00 AM - 09:00 AM PDT	Abstract	8-006 - Autoimmune Hemolytic Anemia Following IVIG Treatment in a Patient with CIDP and Positive Porphobilinogen Testing: A Case Report Filipi F. Andreão
08:00 AM - 09:00 AM PDT	Abstract	8-007 - Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis (AAV) Post COVID Vaccine Presenting as Ischemic Strokes: A Case Report Dana Ghazaleh, MD
08:00 AM - 09:00 AM PDT	Abstract	8-008 - Transverse Myelitis in Context: Investigating the Role of Social Determinants of Health (SDOH) in Clinical Outcomes at a Population Level Ka-Ho Wong
08:00 AM - 09:00 AM PDT	Abstract	8-009 - Immunoglobulin G4-related Disease (IgG4-RD) Masquerading as a Meningioma with Cerebral Sinus Venous Thrombosis (CVST): Nynoshka M. Bassatt Cabrera, MD
08:00 AM - 09:00 AM PDT	Abstract	8-010 - A Case on Primary CNS Lymphomatoid Granulomatosis Kristen Watkins, MD
08:00 AM - 09:00 AM PDT	Abstract	8-011 - ICI-Induced Encephalitis Secondary to Pembrolizumab use in Renal Cell Carcinoma: A Case Report Kunal Malik, MD
08:00 AM - 09:00 AM PDT	Abstract	8-012 - Ventriculitis as a manifestation of Neuropsychiatric Systemic Lupus Erythematosus Ximena A. García-Velazquez
08:00 AM - 09:00 AM PDT	Abstract	8-014 - Presentation of Various Neurological Symptoms Alongside Heerfordt’s Syndrome Leads to the Diagnosis of Sarcoidosis. Johanna S. Canenguez, MD
08:00 AM - 09:00 AM PDT	Abstract	8-015 - A Paradox Unveiled: CMV and ANCA Vasculitis Coexisting Prior to Immunosuppression with Unique Neuroimaging Findings Jamie Harris, BS
08:00 AM - 09:00 AM PDT	Abstract	8-017 - Complement Factor I Deficiency with Acute Hemorrhagic Leukoencephalitis, Myelitis and Relapsing Neuroinflammation Javier Rodriguez
08:00 AM - 09:00 AM PDT	Abstract	8-018 - The Prevalence of Sjogren’s Syndrome-associated Antibodies and Sjogren’s Syndrome in patients with anti-Myelin Oligodendrocyte Glycoprotein Antibodies Mattia Wruble, MD
08:00 AM - 09:00 AM PDT	Abstract	8-019 - Decompressing the Truth: Neurosarcoidosis Manifesting as Compressive Myelopathy? Nora Nikprelevic, MD, MBBS
08:00 AM - 09:00 AM PDT	Abstract	8-020 - Clinical and Magnetic Resonance Imaging Features of Idiopathic Myelitis Asli Buyukkurt, MD
08:00 AM - 09:00 AM PDT	Abstract	9-001 - Long-Term Safety and Efficacy of Azetukalner (XEN1101), a Novel, Potent KV7 Potassium Channel Opener in Adults With Focal Epilepsy: Update From the Ongoing 7-Year Open-Label Extension of X-TOLE Jacqueline French, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	9-002 - Safety and Effectiveness of Fenfluramine for the Treatment of Seizures in Lennox-Gastaut Syndrome: Results From the Final Analysis of an Open-Label Extension Study Heidi L. Henninger, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	9-003 - First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Focal Epilepsy - Updated Clinical Trial Results John D. Hixson, MD
08:00 AM - 09:00 AM PDT	Abstract	9-004 - Time to Prerandomization Seizure Count Design Sufficiently Assessed the Safety and Tolerability of Perampanel for the Treatment of Focal Seizures Lavanya Biju
08:00 AM - 09:00 AM PDT	Abstract	9-005 - Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom Sarah L. Wilson, MD
08:00 AM - 09:00 AM PDT	Abstract	9-006 - Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in a Multinational Asian Population Louis Ferrari
08:00 AM - 09:00 AM PDT	Abstract	9-007 - A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS) Amit Ray, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	9-008 - Long Term Outcomes with Cenobamate Use in an Epilepsy Clinic Batool A. Hussain, MD, MBBS
08:00 AM - 09:00 AM PDT	Abstract	9-009 - Long-term Tolerability and Efficacy of Adjunctive Brivaracetam in Pediatric Patients with Primary Generalized Seizures: Subgroup Analysis of an Open-label, Follow-up Trial Brian D. Moseley, MD
08:00 AM - 09:00 AM PDT	Abstract	9-010 - Early Response Rates With Adjunctive Cenobamate in Uncontrolled Focal Seizures: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in a Multinational Asian Population Pranoti Pradhan
08:00 AM - 09:00 AM PDT	Abstract	9-011 - A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Cenobamate in Asian Patients With Focal Seizures, With Optional Open-Label Extension Sunita N. Misra, MD
08:00 AM - 09:00 AM PDT	Abstract	9-012 - Efficacy of Azetukalner in Focal Onset Seizure (FOS) Subtypes: Results From the Double-Blind, Placebo Controlled X-TOLE Study Constanza Luzon
08:00 AM - 09:00 AM PDT	Abstract	9-013 - Treatment of Status Epilepticus At and After T1 With Diazepam Nasal Spray: A Combined Cohort Analysis Delia Mancoci, MD
08:00 AM - 09:00 AM PDT	Abstract	9-014 - A Stratified Analysis of Efficacy and Safety of Fenfluramine in Patients With Dravet Syndrome Kameron Azarm, PhD
08:00 AM - 09:00 AM PDT	Abstract	9-015 - Impact of Fenfluramine on Convulsive Seizure Frequency in Dose-Capped Patients With Dravet Syndrome Amelie Lothe, PhD
08:00 AM - 09:00 AM PDT	Abstract	9-016 - A Modern Design for a Phase 2/3 Randomized, Double-blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BHV-7000 in Idiopathic Generalized Epilepsy with Generalized Tonic-Clonic Seizures Jason Lerner, MD
08:00 AM - 09:00 AM PDT	Abstract	9-017 - Adjunctive Cenobamate for the Treatment of Primary Generalized Tonic-Clonic Seizures in Adults and Adolescents: Design of a Phase 3 Study With Open-Label Extension Arkady Nisman, PharmD
08:00 AM - 09:00 AM PDT	Abstract	10-001 - Systemic Inflammation and Its Impact on Comorbidities in People with HIV (PWH) Azin Tavasoli, MD
08:00 AM - 09:00 AM PDT	Abstract	10-002 - Increased Levels of GDF15 Protein in the Brain are Associated with Neurocognitive Dysfunction in People with HIV Ali Boustani, MD
08:00 AM - 09:00 AM PDT	Abstract	10-003 - Cerebrospinal Fluid Biomarkers: Beta-Amyloid, Amyloid, Total Tau (t-tau), and Phosphorylated Tau (p-tau181) in Alzheimer’s Dementia in People Living with HIV: A Systematic Review and Meta-Analysis Daniel V. De Siqueira Lima, Jr., MD
08:00 AM - 09:00 AM PDT	Abstract	10-004 - Comparative Analysis of Neuroinfectious Disorders in HIV-Positive and HIV-Negative Patients in Bogotá: A Retrospective Study (2021-2024) Juan D. Oyola, MD
08:00 AM - 09:00 AM PDT	Abstract	10-005 - An Observational Study of Prion Disease Sushuma Yarlagadda, MD
08:00 AM - 09:00 AM PDT	Abstract	10-006 - Biomarker Assessment of Neuropsychological Long COVID Symptoms Taizen Nakase
08:00 AM - 09:00 AM PDT	Abstract	10-007 - Evaluation of Psychiatric History and Symptom Discordance in Neuro-PASC Patients: A Cross-Sectional Study Lina Al Qadi
08:00 AM - 09:00 AM PDT	Abstract	11-001 - Climbing with Caution in High Altitude - A Scoping Review of High-Altitude Cerebral Edema Yugant Khand, MBBS, DiMM
08:00 AM - 09:00 AM PDT	Abstract	11-003 - Understanding the Incidence, Prevalence, Characteristics, and Healthcare Resource Utilization for Patients With Dravet and Lennox-Gastaut Syndromes Rejena Azad, PharmD
08:00 AM - 09:00 AM PDT	Abstract	11-004 - A Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States Rejena Azad, PharmD
08:00 AM - 09:00 AM PDT	Abstract	11-005 - Clinical Trial Emulation Leveraging Genetic Effects: A Proof-of-Concept Application to SPRINT Santiago Clocchiatti-Tuozzo
08:00 AM - 09:00 AM PDT	Abstract	11-006 - Marine Microplastics Levels and the Prevalence of Neurologic Disability Brinda Desai, MBBS
08:00 AM - 09:00 AM PDT	Abstract	11-007 - Economic Disparity in Functional Neurological Disorder: Rising Healthcare Costs, Low Research Investment Christopher D. Stephen, MB ChB, FRCP, MSc, SM
08:00 AM - 09:00 AM PDT	Abstract	11-008 - Nationwide Incidence and Associated Morbidity of Idiopathic Normal Pressure Hydrocephalus in Medicare Beneficiaries Srishti Rajeev
08:00 AM - 09:00 AM PDT	Abstract	11-009 - Relationship between Cycling of Traditional Oral Generic Preventive Medications and Patient-Reported Outcomes: US Results from the Chronic Migraine Epidemiology and Outcomes – International Study Kristina M. Fanning, PhD
08:00 AM - 09:00 AM PDT	Abstract	11-010 - Association Between Hyperlipidemia of the US population and Cerebrovascular Diseases (CVD) Mortality from 1999 to 2020. Aidan Keaveny
08:00 AM - 09:00 AM PDT	Abstract	11-012 - Trends in Mortality due to Cerebrovascular Diseases in Patients with Underlying Hypertension: A US Analysis from 1999 to 2020 Edwin J. Serrano, MD
08:00 AM - 09:00 AM PDT	Abstract	11-013 - Cases-Series of Creutzfeldt-Jakobs Disease in 2 Tertiary Care Hospitals of New York City Umair Ahmed, MD
08:00 AM - 09:00 AM PDT	Abstract	11-014 - Identification of Patients with Incident Parkinson Disease Using ICD-10-CM Codes in Claims Data Jordan A. Killion, PhD
08:00 AM - 09:00 AM PDT	Abstract	11-015 - Analysis of Brain Haemorrhage Related Mortality from 1999-2020 Mohammad Ammar Ur Rahman, MBBS
08:00 AM - 09:00 AM PDT	Abstract	11-016 - Trend-Analysis of Cerebral Infarction-Related Mortality from 1999-2020 Mohammad Ammar Ur Rahman, MBBS
08:00 AM - 09:00 AM PDT	Abstract	11-017 - COVID-19 Infection is Associated with Stroke Subtype, Severity, and Outcomes in Patients with Acute Ischemic Stroke Anna Belits, DO
08:00 AM - 09:00 AM PDT	Abstract	11-018 - The COVID-19 Pandemic Significantly Affected Acute Ischemic Stroke Subtype, Patient Characteristics, and Outcomes Anna Belits, DO
08:00 AM - 09:00 AM PDT	Abstract	11-020 - Twenty-Year Disparity Trends in U.S. Sleep Disorder Mortality by Age, Race/Ethnicity, Geography, and Socioeconomic Status. Lauren Fife
08:00 AM - 09:00 AM PDT	Abstract	11-021 - Divergent Mortality Associated with Parkinson-related Dementia in the United States: 1999-2020 Lauren Fife
08:00 AM - 09:00 AM PDT	Abstract	11-022 - Who Shows Up? Attendance Trends Across Different Neurology Clinics at an Urban Safety-Net Hospital Matthias Dunse, MD
08:00 AM - 09:00 AM PDT	Abstract	11-023 - Averaged Blink Reflex Potential: A Novel Method of Monitoring for Intraoperative Facial Nerve Injury Rohit Gummi, MD
08:00 AM - 09:00 AM PDT	Abstract	11-024 - Use of Intraoperative Neurophysiologic Monitoring (IONM) to Detect Successful Cryoablation in a Robotic-Assisted Thoracic Surgery (RATS) - A Case Report Mark Keroles, MD
08:00 AM - 09:00 AM PDT	Abstract	11-026 - Anomalous Dual Innervation of the Extensor Digitorum Brevis by the Tibial and Fibular Nerves: A Case Report Sepideh Allahdadian, MD
08:00 AM - 09:00 AM PDT	Abstract	11-027 - The Utility of Measuring Aldolase Levels in Patients Undergoing Evaluation for Myopathy Samantha Levin, MD
08:00 AM - 09:00 AM PDT	Abstract	11-028 - The Morphological Changes in The Median Nerve Following Carpal Tunnel Release: A Systematic Review and Meta-analysis Ahmed Negida, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	11-029 - Neuromuscular Ultrasound Uncovers Hypertrophic Accessory Abductor Digiti Minimi Muscle Causing Ulnar Nerve Compression Soheil El-Azzouni, MD
08:00 AM - 09:00 AM PDT	Abstract	11-030 - Microvascular Decompression for Trigeminal Neuralgia: Assessment of Modality Utility Unaiza Memon
08:00 AM - 09:00 AM PDT	Abstract	11-031 - Risk of “False Positivity” Associates with Acetylcholine Receptor Autoantibody Titer by Radioimmunoprecipitation Assay Pietro Zara, MD
08:00 AM - 09:00 AM PDT	Abstract	11-032 - Design of a Digital Solution to Improve Myasthenia Gravis Patient Symptom Tracking in Routine Clinical Care Srikanth Muppidi, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	11-033 - Feasibility of a Low-cost Quantitative Continuous Measurement of Movements in the Extremities for Live and Remote Evaluation of People with Possible Myasthenia Gravis and Related Neuromuscular Disorders James R. Brasic, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	11-034 - Improving Bone Health Screening in Patients with Spinal Muscular Atrophy: A Quality Improvement Initiative Erin McCoy, MD
08:00 AM - 09:00 AM PDT	Abstract	12-001 - Characterizing Within Participant Consistency of Prodromal Symptoms in Migraine: Results from the PRODROME Trial Screening Period Todd J. Schwedt, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	12-002 - Exploratory Efficacy Results from the TANDEM Trial: Safety, Tolerability, and Efficacy of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine Nicole Naccara
08:00 AM - 09:00 AM PDT	Abstract	12-003 - Exploring the Association Between Statins Use or HMG-CoA Reductase Inhibition and Migraine Risk Reduction and Disease Prophylaxis: A Comprehensive Systematic Review and Meta-Analysis Ahmed Negida, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	12-004 - Comparative Efficacy and Safety of Tricyclic Antidepressants (TCAs) Versus Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Migraine Prophylaxis: A Systematic Review and Meta-Analysis Advait Teli, MBBS
08:00 AM - 09:00 AM PDT	Abstract	12-006 - Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Japan Robert Fountaine
08:00 AM - 09:00 AM PDT	Abstract	12-007 - Efficacy and Safety of Rimegepant for the Prevention of Migraine in Japan Robert Fountaine
08:00 AM - 09:00 AM PDT	Abstract	13-001 - Delayed Hemorrhagic Venous Infarction Following Subthalamic Nucleus Electrode Array Placement Brandon Donley, MD
08:00 AM - 09:00 AM PDT	Abstract	13-002 - May-Thurner Syndrome Presenting as Recurrent Embolic Stroke of Undetermined Source Associated with a Low Risk of Paradoxical Embolism Score Angel Hadaway, MD
08:00 AM - 09:00 AM PDT	Abstract	13-003 - Paradoxical Embolism Secondary to Asymptomatic Venous Thoracic Outlet Syndrome Shumaila Anwer, MD
08:00 AM - 09:00 AM PDT	Abstract	13-004 - Anomalous Brachiocephalic Vein Resulting in Stroke via Paradoxical Embolism: A Case Report Samantha Blum, DO
08:00 AM - 09:00 AM PDT	Abstract	13-005 - Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report Amita Bose
08:00 AM - 09:00 AM PDT	Abstract	13-006 - Migraine with Aura and Stroke Risk in a Young Adult: A Case of Migrainous Infarct” Golnoush Akhlaghipour, MD
08:00 AM - 09:00 AM PDT	Abstract	13-007 - Tenecteplase in a Pediatric Patient with Acute Ischemic Stroke Omair Ul Haq Lodhi, MBBS
08:00 AM - 09:00 AM PDT	Abstract	13-008 - Does Diabetes Mellitus Influence the Association Between Stress Hyperglycemia and Leptomeningeal Collateral Circulation in Acute Ischemic Stroke Patients? Emanuele Camerucci, MD
08:00 AM - 09:00 AM PDT	Abstract	13-009 - Crack a Few Backs to Make an Embolus Mahmoud A. Almady, MD
08:00 AM - 09:00 AM PDT	Abstract	13-010 - Moyamoya Disease in Latin America: A Case Report with Systematic Review and Meta-Analysis Brigith R. Avila Lucas, Sr., MD
08:00 AM - 09:00 AM PDT	Abstract	13-012 - Tumor Embolic Stroke and Endovascular Thrombectomy: A Literature Review Vishnu V. Byroju, MD
08:00 AM - 09:00 AM PDT	Abstract	13-013 - From Headaches to Hemorrhages: The Hidden Journey of Amyloid Beta Related Angiitis Genaro E. Herrera Cano
08:00 AM - 09:00 AM PDT	Abstract	13-014 - The Origins of Posterior Communicating Artery Variations in the Circle of Willis Mathilde Langlois, BSc
08:00 AM - 09:00 AM PDT	Abstract	13-015 - Dragon’s Breath: Diffuse Cortical Infarcts and Leukoencephalopathy after “Chasing the Dragon” with Fentanyl Haia Hazim, DO
08:00 AM - 09:00 AM PDT	Abstract	13-016 - Unraveling the Clinical Puzzle of Cerebral Venous Sinus Thrombosis in Ulcerative Colitis: Insights from a Systematic Review Ahmed Negida, MD, PhD
08:00 AM - 09:00 AM PDT	Abstract	13-017 - The Effect of Insurance Status on Ischemic Stroke Patient Outcomes: A Retrospective Analysis Faraz Arshad
08:00 AM - 09:00 AM PDT	Abstract	13-018 - Patients Receiving Remote Ischemic Conditioning in Early Stroke (PRICES) in the Philippines: An Open-Label Trial KEVIN ROYCE ANG, MD, RN
08:00 AM - 09:00 AM PDT	Abstract	13-019 - Breaking the Silence: Illuminating Racial Disparities in Stroke and Post-stroke aphasia Victor Ekuta, MD
08:00 AM - 09:00 AM PDT	Abstract	14-001 - Contrast-Induced Cerebritis Leading to Acute Hemiparesis Daniela Lozano, MD
08:00 AM - 09:00 AM PDT	Abstract	14-002 - Azygos Anterior Cerebral Artery Occlusion Presenting with Acute Paraparesis: A Myelopathy Mimic Rafail A. Chionatos, MD
08:00 AM - 09:00 AM PDT	Abstract	14-003 - Large Pontine Infarct Without Residual Deficits Karolina D. Perez
08:00 AM - 09:00 AM PDT	Abstract	14-004 - Diagnostic Utility of Genetic Testing in Patients with Carotid Artery Dissection Jordan Langford, MD
08:00 AM - 09:00 AM PDT	Abstract	14-005 - Clinical and Diagnostic Characteristics of Stroke in Young Adults in the TAPESTRY Study Gyanendra Kumar, MD, FAAN
08:00 AM - 09:00 AM PDT	Abstract	14-006 - Stroke in a patient with Sturge Weber Syndrome: Is thrombolysis worth the risk? Jayant K. Yadav, MD
08:00 AM - 09:00 AM PDT	Abstract	14-007 - The Need for Intracranial Aneurysm Screening in Autosomal Dominant Polycystic Kidney Disease : An Updated Systematic Review and Meta-Analysis Claudia Cruzalegui Bazán
08:00 AM - 09:00 AM PDT	Abstract	14-008 - Reversible Cerebral Vasoconstriction Syndrome (RCVS) Following a Carotid Endarterectomy (CEA) – Case Report Natasha Khan, MD
08:00 AM - 09:00 AM PDT	Abstract	14-009 - Bilateral Medial Medullary Infarction Mimicking Guillain-Barre Syndrome Abhishek Vyas
08:00 AM - 09:00 AM PDT	Abstract	14-010 - The Association of Lipoprotein(a) with Ischemic Stroke in Saudi Arabia Muna Alnamlah, MBBS
08:00 AM - 09:00 AM PDT	Abstract	14-012 - Congenital Thrombotic Thrombocytopenic Purpura Presenting as Extensive Multifocal Ischemic Strokes with Aphasia and Hemiplegia in a 3-year-old Male Patient Melissa Mizerik, DO
08:00 AM - 09:00 AM PDT	Abstract	14-013 - Acute Ischemic Stroke In a Patient with Neonatal Marfan’s Syndrome Gautham V. Upadrasta, MD
08:00 AM - 09:00 AM PDT	Abstract	14-014 - A Tale of Two Brothers: Two Cases of Symptomatic Heterozygous HTRA1 Mutations Benjamin D. Sacks, MBBS
08:00 AM - 09:00 AM PDT	Abstract	14-015 - Recurrent Cerebral Ischemic Events in a Patient with a POLG Gene Mutation: A Case Report TAIS L. DENICOL, MD
08:00 AM - 09:00 AM PDT	Abstract	14-016 - Evaluating the Role of Interferon Gamma in the Hyper Acute Phase of Stroke in a Mouse Model Safia Sharif

Faculty Disclosures
Brandon Donley, MD	Dr. Donley has nothing to disclose.
Haroutiun Hamzoian, MD	Dr. Hamzoian has nothing to disclose.
Christine Ochoa, MD	Dr. Ochoa has nothing to disclose.
Audrey Huang	Miss Huang has nothing to disclose.
Jenny Yang, MD	Miss Yang has nothing to disclose.
William Liu	Mr. Liu has nothing to disclose.
Deepika Dilip	Ms. Dilip has nothing to disclose.
Nimrod Gozum	Mr. Gozum has nothing to disclose.
Gular Mammadli, MD	Dr. Mammadli has nothing to disclose.
Hasit Mehta, MD	Dr. Mehta has nothing to disclose.
Stephan A. Mayer	No disclosure on file
Colleen Bond, PharmD	Mrs. Bond has nothing to disclose.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright MInds Bioscience. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobah. Dr. Porter has received publishing royalties from a publication relating to health care.
Emilio Perucca	Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN Therapeutics. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sun Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Xenon Pharma. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care.
Martin Brodie	Martin Brodie has nothing to disclose.
Cynthia Harden	No disclosure on file
Jenny Qian	Jenny Qian has nothing to disclose.
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Christopher Kenney	No disclosure on file
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Piyush Roy, MBBS	Mr. Roy has nothing to disclose.
Yugant Khand, MBBS, DiMM	Dr. Khand has nothing to disclose.
Shraddha Mainali, MD	Dr. Mainali has received personal compensation for serving as an employee of Virginia commonwealth University.
Azin Tavasoli, MD	Dr. Tavasoli has nothing to disclose.
Mohammadsobhan Sheikh Andalibi, MD	Dr. Sheikh Andalibi has nothing to disclose.
Raha M. Dastgheyb, PhD	The institution of Prof. Dastgheyb has received research support from NIH.
Scott L. Letendre, MD	The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
Ronald J. Ellis, MD, PhD, FAAN	Dr. Ellis has nothing to disclose.
Gemma Olivé, MD	Dr. Olivé has nothing to disclose.
Elianet Fonseca, MD	Dr. Fonseca has nothing to disclose.
Li-Wen Chen, MD, PhD	Dr. Chen has received research support from National Cheng Kung University Hospital.
Anna Fetta, MD	Dr. Fetta has nothing to disclose.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Mar Guasp, MD	Dr. Guasp has nothing to disclose.
Veronica Gonzalez, PhD	Mrs. Gonzalez has nothing to disclose.
Veronica Delgadillo, Sr., MD	Mrs. Delgadillo has nothing to disclose.
Verónica Cantarin-Extremera, MD, PhD	Mrs. Cantarin-Extremera has nothing to disclose.
María Jiménez Legido, MD	Mrs. Jiménez Legido has nothing to disclose.
Lorena Monge-Galindo, MD	Dr. Monge-Galindo has nothing to disclose.
Ana Felipe, MD	Dr. Felipe has nothing to disclose.
Beatriz Beseler, MD	Dr. Beseler has nothing to disclose.
Eulalia Turon-Vinas, MD, PhD	Dr. Turon-Vinas has received personal compensation for serving as an employee of Eisai. Dr. Turon-Vinas has received personal compensation for serving as an employee of UCB. Dr. Turon-Vinas has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Turon-Vinas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.
Joaquín Alejandro Fernández Ramos, MD	Dr. Fernández Ramos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Maria-Jesus Martinez-Gonzalez, MD	Mrs. Martinez-Gonzalez has nothing to disclose.
Maria V. Lopez, MD, PhD	Dr. lopez has nothing to disclose.
LUISA ARRABAL, PhD	Ms. ARRABAL has received personal compensation in the range of $0-$499 for serving as a Consultant for JAZZ. Ms. ARRABAL has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for JAZZ.
Mireia Alvarez, MD	Dr. Alvarez has nothing to disclose.
Beatriz Muñoz, PhD	Dr. Muñoz has nothing to disclose.
Ana C. Salas, MD	Mr. Salas has nothing to disclose.
NOEMI N. ENAMORADO, PhD	Mrs. ENAMORADO has nothing to disclose.
Marianna Spatola, MD, PhD, FAAN	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil.
Lidia Sabater, PhD	The institution of Dr. Sabater has received research support from Instituto de Salud Carlos III.
Yolanda Blanco Morgado, MD	Dr. Blanco Morgado has nothing to disclose.
Albert Saiz	Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Francesc R. Graus, MD	Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Shari M. Duarte, MD	Dr. Duarte has nothing to disclose.
Abdul Gaffar Mohammed, MBBS	Dr. Mohammed has nothing to disclose.
Lauren T. Southerland, MD	The institution of Dr. Southerland has received research support from NIH. Dr. Southerland has received personal compensation in the range of $0-$499 for serving as a speaker with The Geriatric Emergency Department Collaborative.
Sean Culver, MD	Dr. Culver has nothing to disclose.
Erin Reichert, PharmD	Mrs. Reichert has nothing to disclose.
Katherine Hunold, MD	Dr. Hunold has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American College of Emergency Physicians.
Douglas W. Scharre, MD, FAAN	Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Catherine Boldig, DO	Dr. Boldig has nothing to disclose.
Armando Martinez Salazar, MD	Dr. Martinez Salazar has nothing to disclose.
Luke T. Hong, MD	Dr. Hong has nothing to disclose.
Edwin N. Peguero, MD	Dr. Peguero has nothing to disclose.
Muhammad H. Jaffer, MD	Dr. Jaffer has nothing to disclose.
Sepideh Mokhtari, MD	Dr. Mokhtari has nothing to disclose.
Daniela Lozano, MD	Dr. Lozano has nothing to disclose.
Taleen Shahrigian, DO	Dr. Shahrigian has nothing to disclose.
Bradley Haveman-Gould, PA	Mr. Haveman-Gould has nothing to disclose.
Muhammad Farooq, MD	Dr. Farooq has nothing to disclose.
Shannon Gu, MD	Ms. Gu has nothing to disclose.
Shaina C. Anderson	Ms. Anderson has nothing to disclose.
Roshini Chandrasekhar, MD	Ms. Chandrasekhar has nothing to disclose.
Amanda R. Gamboa	Miss Gamboa has nothing to disclose.
Beom Ho Lee, MD	Mr. Lee has nothing to disclose.
Cheyenne N. Lockwood, MD	Ms. Lockwood has nothing to disclose.
Fadi S. Hanna Al-Shaikh, MD	Mr. Hanna Al-Shaikh has nothing to disclose.
Katherine Bailey	Mrs. Bailey has nothing to disclose.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. Dr. Schwedt has stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Logan Roberts, PhD	Dr. Roberts has received personal compensation for serving as an employee of AbbVie. Dr. Roberts has stock in AbbVie.
Yingyi Liu	Yingyi Liu has received personal compensation for serving as an employee of AbbVie.
Elimor Brand-Schieber, PhD	Dr. Brand-Schieber has received personal compensation for serving as an employee of AbbVie. Dr. Brand-Schieber has stock in AbbVie.
Janette Contreras-De Lama	Janette Contreras-De Lama has received personal compensation for serving as an employee of AbbVie. Janette Contreras-De Lama has stock in AbbVie.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Annette M. Langer-Gould, MD, PhD	An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Bonnie Li	Bonnie Li has received personal compensation for serving as an employee of Kaiser Permanente.
Jessica B. Smith, MPH	Ms. Smith has nothing to disclose.
michael h. kanter, MD	Dr. kanter has a non-compensated relationship as a advisory committee member with national quality forum that is relevant to AAN interests or activities. Dr. kanter has a non-compensated relationship as a practice improvement committee member with society to improve diagnosis in medicine that is relevant to AAN interests or activities. Dr. kanter has a non-compensated relationship as a editorial board member with joint commission journal on quality and patient safety that is relevant to AAN interests or activities.
Kristen Choi, NP	The institution of Dr. Choi has received research support from NIH. The institution of Dr. Choi has received research support from Gordon & Betty Moore Foundation. The institution of Dr. Choi has received research support from AARP.
Stanley Xu	No disclosure on file
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for alkermes. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for centessa. Dr. Thorpy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Gregory S. Parks, PhD	Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Samantha Floam, DMD	Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
Eileen Leary, PhD	Dr. Leary has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Leary has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Partners Group. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulse Infoframe. Dr. Leary has or had stock in Jazz Pharmaceuticals.Dr. Leary has or had stock in Axsome Therapeutics.Dr. Leary has or had stock in Centessa Pharmaceuticals.
Herriot Tabuteau	Herriot Tabuteau has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Axsome Therapeutics.
Amy Kant	Amy Kant has nothing to disclose.
Keith Harper	Keith Harper has nothing to disclose.
Ali Boustani, MD	Dr. Boustani has nothing to disclose.
Mary K. Ford	Miss Ford has nothing to disclose.
Jacqueline R. Kulbe, MD, PhD	Dr. Kulbe has nothing to disclose.
Anna Laird	Ms. Laird has nothing to disclose.
Leeann V. Shu	Miss Shu has nothing to disclose.
Matthew Spencer	Mr. Spencer has nothing to disclose.
Jerel A. Fields, PhD	Dr. Fields has received intellectual property interests from a discovery or technology relating to health care.
Rafail A. Chionatos, MD	Dr. Chionatos has nothing to disclose.
Camelia Valhuerdi Porto, MD	Dr. Valhuerdi Porto has nothing to disclose.
Nikita Srinivasan, MBBS	Dr. Srinivasan has nothing to disclose.
Naman Bareja, MBBS	Dr. Bareja has nothing to disclose.
Aleksandra Yakhkind, MD	Dr. Yakhkind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LangAware. Dr. Yakhkind has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Yakhkind has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Round Table Group. Dr. Yakhkind has received research support from Sara's Wish Foundation Global Health Grant. Dr. Yakhkind has received publishing royalties from a publication relating to health care. Dr. Yakhkind has a non-compensated relationship as a Faculty with Massachusetts General Hospital CME that is relevant to AAN interests or activities.
Lisa Scott, MD, DO	Dr. Scott has nothing to disclose.
Maryam Bahadori, MD	Dr. Bahadori has nothing to disclose.
Angel Hadaway, MD	Dr. Hadaway has nothing to disclose.
Daniel Moreno-Zambrano, MD	Dr. Moreno-Zambrano has nothing to disclose.
Ariol Labrada, MD	Dr. Labrada has nothing to disclose.
Roberto E. Sanchez, MD	Dr. Sanchez has nothing to disclose.
Justin R. Wheelock	Mr. Wheelock has nothing to disclose.
Yilun Chen	Ms. Chen has nothing to disclose.
Jacob Garetti	Mr. Garetti has nothing to disclose.
Haoqi Sun, PhD	Dr. Sun has nothing to disclose.
jin jing, PhD	Dr. jing has received publishing royalties from a publication relating to health care.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Adithya Sivaraju, MD	Dr. Sivaraju has nothing to disclose.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Jennifer A. Kim, MD	Dr. Kim has nothing to disclose.
Yongli Zhao, PhD	Miss Zhao has nothing to disclose.
Siddharth Satish, Student	Mr. Satish has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Amrapali Patel, MD	Dr. Patel has nothing to disclose.
Maya Mastick	Ms. Mastick has nothing to disclose.
Seungwon Lee, BA	Miss Lee has nothing to disclose.
Andrew Siyoon Ham	Andrew Siyoon Ham has nothing to disclose.
Gladia C. Hotan	Ms. Hotan has received research support from Institute of High Performance Computing.
Tina Chen	Miss Chen has nothing to disclose.
Emily Tsai	Ms. Tsai has nothing to disclose.
Molly He	Molly He has nothing to disclose.
Jonathan H. Smith, MD	Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Casey Schlacher, RN	Ms. Schlacher has received personal compensation for serving as an employee of AbbVie. Ms. Schlacher has stock in AbbVie.
Linda Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly . Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly.
Thomas W. Johnson, MD, PhD	Dr. Johnson has nothing to disclose.
Lauren M. Zoghlin, MD	Dr. Zoghlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Zoghlin has received personal compensation in the range of $0-$499 for serving as a participant nonbranded educational session, received dinner with Genentech.
Ana Beatriz Serafim, MSc	Miss Serafim has received research support from Fundação para as ciências e tecnologia.
Mateus M. Simabukuro, MD	Dr. Simabukuro has nothing to disclose.
Ángel Ortega-González, MD	Dr. Ortega-González has nothing to disclose.
Michael Kruer, MD	Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Debra E. Weese-Mayer, MD	The institution of Dr. Weese-Mayer has received research support from NIH. The institution of Dr. Weese-Mayer has received research support from FDA.
Casey Rand, MS	Mr. Rand has nothing to disclose.
Carme Fons, MD, PhD	Dr. Fons has nothing to disclose.
Maria Clemente, PhD	Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DEXCOM. Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVONORDISK. Dr. Clemente has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AIRLIQUIDE.
Emília K. Leão, MD	Dr. Leão has nothing to disclose.
Salvador Ibanez-Mico, MD	Dr. Ibanez-Mico has nothing to disclose.
Stephen N. Gomperts, MD, PhD, FAAN	Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
John-Paul Taylor, MBBS, PhD	Prof. Taylor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. The institution of Prof. Taylor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cervomed. Prof. Taylor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. Prof. Taylor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Prof. Taylor has received research support from NIHR. The institution of Prof. Taylor has received research support from Alzheimer's Research UK. The institution of Prof. Taylor has received research support from Alzheimer's Society. Prof. Taylor has received publishing royalties from a publication relating to health care.
Amanda Gardner	Mrs. Gardner has received personal compensation for serving as an employee of CervoMed. An immediate family member of Mrs. Gardner has received personal compensation for serving as an employee of Abbott Laboratories. Mrs. Gardner has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for CervoMed. Mrs. Gardner has stock in CervoMed. An immediate family member of Mrs. Gardner has stock in Abbott Laboratories.
Niels D. Prins, MD	Dr. Prins has stock in Brain Research Center. Dr. Prins has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with Brain Research Center.
Kelly Blackburn	Ms. Blackburn has received personal compensation for serving as an employee of CervoMed Inc. Ms. Blackburn has received personal compensation in the range of $0-$499 for serving as a Consultant for AkiraBio. Ms. Blackburn has received personal compensation in the range of $0-$499 for serving as a Consultant for BluePrint. Ms. Blackburn has stock in CervoMed.
John Alam	John Alam has received personal compensation for serving as an employee of CervoMed. John Alam has or had stock in CervoMed.
Lawrence S. Honig, MD, PhD, FAAN	Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
James E. Galvin, MD, MPH	Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Matthew Swan, MD, FAAN	The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics. The institution of Dr. Swan has received research support from Parkinson's Foundation. The institution of Dr. Swan has received research support from Photopharmics. The institution of Dr. Swan has received research support from Denali Therapeutics. The institution of Dr. Swan has received research support from NOEMA Pharma.
Christine Low, MSW	Mrs. Low has nothing to disclose.
Jared Kutzin, RN, DNP, MS, MPH	Dr. Kutzin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAMC .
Leona Hess, PhD	Dr. Hess has nothing to disclose.
Andrea Lendaris, MD, MS	Dr. Lendaris has nothing to disclose.
Kelly G. Knupp, MD	The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Berten Ceulemans	No disclosure on file
Joseph E. Sullivan, MD	Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrightMinds. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Sullivan has stock in Zynerba. The institution of Dr. Sullivan has received research support from Stoke. The institution of Dr. Sullivan has received research support from Takeda. The institution of Dr. Sullivan has received research support from Neurocrine. The institution of Dr. Sullivan has received research support from Encoded. The institution of Dr. Sullivan has received research support from Zogenix.
Katherine C. Nickels, MD, FAAN	The institution of Dr. Nickels has received research support from Zogenix. The institution of Dr. Nickels has received research support from Marinus. The institution of Dr. Nickels has received research support from Bio-Pharm Solutions. The institution of Dr. Nickels has received research support from Pediatric Epilepsy Research Foundation. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Faculty with J. Kiffin Penry ��ɫ��al Programs.
Lieven G. Lagae, PhD	Dr. Lagae has nothing to disclose.
Renzo Guerrini	Renzo Guerrini has nothing to disclose.
Sameer M. Zuberi, MD	Prof. M ZUBERI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GRIN Therapeutics. Prof. M ZUBERI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded Therapeutics. Prof. M ZUBERI has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Prof. M ZUBERI has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma.
Rima Nabbout	Rima Nabbout has nothing to disclose.
Kate Riney	No disclosure on file
Michael Lock, PhD	Dr. Lock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for UCB. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meissa.
David Dai, PhD	Dr. Dai has nothing to disclose.
Ronald G. Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ucb.
Diego Morita, MD	Dr. Morita has received personal compensation for serving as an employee of UCB Biosciences, Inc. Dr. Morita has stock in UCB, Inc.
Amelie Lothe, PhD	Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB.
Melanie LANGLOIS	Melanie LANGLOIS has received personal compensation for serving as an employee of UCB Pharma. Melanie LANGLOIS has stock in UCB Pharma.
Rebecca Zhang-Roper, MD, PhD	Dr. Zhang-Roper has received personal compensation for serving as an employee of UCB. Dr. Zhang-Roper has stock in UCB.
Timothy Minh	Mr. Minh has received personal compensation for serving as an employee of UCB. Mr. Minh has stock in UCB.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Belal M. Hamed, Jr., Medical student	Dr. Hamed has nothing to disclose.
Somaia Kassab, Jr., MD	Dr. Kassab has nothing to disclose.
‪Ekram H. Hasanin‬‏	Miss Hasanin?? has nothing to disclose.
Shaimaa S. Abdelgawad, MBBS	Dr. Abdelgawad has nothing to disclose.
Mohamed Zeyada	Dr. Zeyada has nothing to disclose.
Abdelbaki IDRISS IBRAHIM, MBBS	Dr. IDRISS IBRAHIM has nothing to disclose.
Ibrahim Hassan, MD	Dr. Hassan has nothing to disclose.
Anas M. Elgenidi, MD	Dr. Elgenidi has nothing to disclose.
Menna A. Shehab	Menna A. Shehab has nothing to disclose.
Yasser Hamed, MD, PhD	Prof. Hamed has nothing to disclose.
Osama Abuel-naga, MD, PhD	No disclosure on file
Hazem Abdel-Rahman, MD, PhD	Prof. Abdel-Rahman has nothing to disclose.
Hoda Atef A. Ibrahim, MD, PhD	Dr. Atef A. Ibrahim has nothing to disclose.
Amira Elhoufey, PhD	No disclosure on file
Hamad Dailah, PhD	Prof. Dailah has nothing to disclose.
Khaled Saad, MD, PhD	Prof. Saad has nothing to disclose.
Deborah Nichols, MS	No disclosure on file
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Teresa Steininger	Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
Douglas S. Fuller	Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Todd Kirby, PhD	Dr. Kirby has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Kirby has stock in Jazz Pharmaceuticals.
Sarah Akerman, MD	Dr. Akerman has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Akerman has stock in Jazz Pharmaceuticals.
Jessica K. Alexander, PhD	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Alyssa Cairns, PhD	Dr. Cairns has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Cairns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
Rebeca O. Silva, Student	Miss Silva has nothing to disclose.
Daniel V. De Siqueira Lima, Jr., MD	Dr. De Siqueira Lima has nothing to disclose.
Yasmin B. Lima	Miss Lima has nothing to disclose.
João Pedrosa	Mr. Pedrosa has nothing to disclose.
Lívia B. Cavalcanti, Medical Student	Ms. Cavalcanti has nothing to disclose.
Saul Dominici, Sr.	Dr. Dominici has nothing to disclose.
Elizabeth H. de Farias II, medical academic	Mrs. de Farias has nothing to disclose.
Maria E. Valverde, Student	Miss Valverde has nothing to disclose.
Milene Z. Capitanio, MS2	Ms. Capitanio has nothing to disclose.
Niels V. Pacheco, MD	Mr. Pacheco has nothing to disclose.
Arthur P. Corvelo, Sr., Estudante de medicina	Mr. Corvelo has nothing to disclose.
Elison E. Araujo Lima, MD	Dr. Araujo Lima has nothing to disclose.
Anderson Matheus P da Silva, Sr., PhD	Prof. P da Silva has nothing to disclose.
tomohide ando, MD	Dr. ando has nothing to disclose.
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
Karolina D. Perez	Ms. Perez has nothing to disclose.
Firas Kaddouh, MD	Dr. Kaddouh has nothing to disclose.
Sean Lee, MD	Dr. Lee has nothing to disclose.
Ryan Afreen	Ms. Afreen has nothing to disclose.
Bahie Ezzat, MD	Mr. Ezzat has nothing to disclose.
Roshini Kalagara, BA	Miss Kalagara has nothing to disclose.
Neha Dangayach, MD, FAAN	Dr. Dangayach has nothing to disclose.
Christopher P. Kellner, MD	Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. Dr. Kellner has stock in Radical. Dr. Kellner has stock in Reach Neuro. Dr. Kellner has stock in Aurenar. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Isabel Allen, Jr., PhD	Prof. Allen has nothing to disclose.
Rian L. Bogley	Mr. Bogley has nothing to disclose.
Julia Seaman, PhD	Dr. Seaman has nothing to disclose.
Wendy Tobias, EdD	Dr. Tobias has nothing to disclose.
Cecile Puretz, MA	Ms. Puretz has nothing to disclose.
Clarissa C. Kripke, MD	Dr. Kripke has nothing to disclose.
pat osullivan, EdD	Dr. osullivan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
David Irby, PhD	Prof. Irby has nothing to disclose.
Maria Luisa Gorno Tempini, MD, PhD	The institution of Dr. Gorno Tempini has received research support from the NIH.
Zachary Miller, MD	Dr. Miller has nothing to disclose.
Jo Cummins	Ms. Cummins has nothing to disclose.
Emily Eijansantos, MD	Dr. Eijansantos has nothing to disclose.
Jiaming Ji, MD	Dr. Ji has nothing to disclose.
chaojin chen	No disclosure on file
Fumihiro Takahashi, PhD	Dr. Takahashi has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Takatomo Yoneoka, Sr., MS	Mr. Yoneoka has nothing to disclose.
Manabu Hirai	Mr. Hirai has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Daniel Selness	Mr. Selness has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Vesna Todorovic, MD	Dr. Todorovic has nothing to disclose.
Arthur Wamil, MD, PhD	Dr. Wamil has received personal compensation for serving as an employee of Mitsubishi Tanabe.
Nissim Sasson, Sr.	Mr. Sasson has nothing to disclose.
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Ushirogawa Yoshiteru, MPH	Mr. Yoshiteru has nothing to disclose.
Rejena Azad, PharmD	Dr. Azad has received personal compensation for serving as an employee of UCB Pharma.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Amelia Boehme, PhD	Dr. Boehme has nothing to disclose.
Patrick Healy, MS	Mr. Healy has stock in UCB Biosciences.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from ��ɫ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Lawrence P. Goldstick, MD	Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for emd serono. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis genzyme. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TGA therapeutics. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for bristol meyers squibb. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genentech. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi aventis genzyme. Dr. Goldstick has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Goldstick has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TGA therapeutics. The institution of Dr. Goldstick has received research support from biogen. The institution of Dr. Goldstick has received research support from lily. The institution of Dr. Goldstick has received research support from sanofi Aventis genzyme. The institution of Dr. Goldstick has received research support from genetech.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ewa Krzystanek	Ewa Krzystanek has nothing to disclose.
Dusanka Zecevic	Dusanka Zecevic has nothing to disclose.
Catarina Figueiredo	Catarina Figueiredo has nothing to disclose.
Susanne Clinch	Susanne Clinch has stock in F. Hoffmann-La Roche.
Caroline Giacobino	Caroline Giacobino has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Caroline Giacobino has stock in F. Hoffmann-La Roche AG.
Jay Azmi	Jay Azmi has nothing to disclose.
Diego Centonze	Diego Centonze has nothing to disclose.
heather romero, PhD	Dr. romero has received personal compensation for serving as an employee of Takeda. Dr. romero has stock in Takeda.
Yulia Savva, PhD	Dr. Savva has stock in Takeda. Dr. Savva has stock in Thermo Fischer.
Stephen Crawford, PhD	Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda.
Peter McPherson, DPsych (Clin)	Dr. McPherson has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
Helen A. Doll, PhD	Dr. Doll has nothing to disclose.
Amy Howerter, PhD	Dr. Howerter has received personal compensation for serving as an employee of Clinical Outcomes Solutions.
Tara Symonds, PhD	Dr. Symonds has nothing to disclose.
Todd J. Swick, MD, FAAN	Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has stock in Takeda Pharmaceuticals.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
Andrej Roczkowsky	Mr. Roczkowsky has nothing to disclose.
Nathan Armani, PhD	Dr. Armani has nothing to disclose.
Jeffrey Bakal	Jeffrey Bakal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Christopher Power, MD	Dr. Power has nothing to disclose.
Shumaila Anwer, MD	An immediate family member of Dr. Anwer has received personal compensation for serving as an employee of Southwest Airlines. Dr. Anwer has stock in Boeing.
Veronica A. Moreno Gomez, MD	Dr. Moreno Gomez has nothing to disclose.
Merry Joseph	Ms. Joseph has nothing to disclose.
Philip Tatman, MD, PhD	Dr. Tatman has nothing to disclose.
Stephanie Lyden, MD	Dr. Lyden has nothing to disclose.
Vivek Reddy, MD	Dr. Reddy has nothing to disclose.
Alex O'Connor, MD	Alex O'connor has nothing to disclose.
Eric Christiansen, MD	Dr. Christiansen has nothing to disclose.
John D. Hixson, MD	Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Epilepsy Study Consortium.
David C. Spencer, MD, FAAN	Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative ��ɫ�� Concepts.
Kim Burchiel	Kim Burchiel has nothing to disclose.
Harish Babu	Harish Babu has nothing to disclose.
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Jerry J. Shih, MD, FAAN	Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
Sharona Ben-Haim	No disclosure on file
Rebecca O'Dwyer, MD	Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Sepehr Sani	The institution of Sepehr Sani has received research support from NIH. Sepehr Sani has received intellectual property interests from a discovery or technology relating to health care. Sepehr Sani has received publishing royalties from a publication relating to health care.
Derek Southwell	Derek Southwell has nothing to disclose.
Matthew W. Luedke, MD	Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Alphasights . Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Clarivate. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Starnes Davis Florie LLP. Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Huff Powell Bailey. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Gautam Banik	Gautam Banik has received personal compensation for serving as an employee of Neurona Therapeutics.
Marina Bershteyn	Marina Bershteyn has received personal compensation for serving as an employee of Neurona therapeutics. Marina Bershteyn has stock in Neurona therapeutics. Marina Bershteyn has received intellectual property interests from a discovery or technology relating to health care.
Alessandro Bulfone, MD	Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc.
Brianna Feld	Brianna Feld has received personal compensation for serving as an employee of Neurona Therapeutics.
Holly Finefrock	Ms. Finefrock has received personal compensation for serving as an employee of Neurona Therapeutics.
Luis Fuentealba	Luis Fuentealba has nothing to disclose.
Ji-Hye Jung	Ji-Hye Jung has nothing to disclose.
Tia Kowal	Tia Kowal has received personal compensation for serving as an employee of Neurona Tharapeutics. Tia Kowal has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist with Neurona Theraputics.
Sonja Kriks	Sonja Kriks has received personal compensation for serving as an employee of Neurona Therapeutics. Sonja Kriks has stock in Neurona Therapeutics. Sonja Kriks has received intellectual property interests from a discovery or technology relating to health care.
Rose Larios, PhD	Dr. Larios has received personal compensation for serving as an employee of Neurona Therapeutics.
Seonok Lee	Seonok Lee has received personal compensation for serving as an employee of Neurona Therapeutics.
Sheri Madrid	Mrs. Madrid has nothing to disclose.
Yves Maury	Yves Maury has received personal compensation for serving as an employee of Neurona Therapeutics. Yves Maury has stock in Neurona therapeutics.
Catherine Priest, PhD	Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Catherine Priest has received research support from CIRM.
Sergei Shevchuk	Sergei Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics.
Manher Joshi, MD	Dr. Joshi has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Joshi has stock in Atara Biotherapeutics.
Cory R. Nicholas, PhD	Dr. Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Nicholas has stock in Neurona Therapeutics. Dr. Nicholas has received intellectual property interests from a discovery or technology relating to health care.
Shrouk Ramadan, MD	Dr. Ramadan has nothing to disclose.
Amr Hassan, MD	Dr. Hassan has nothing to disclose.
Moaz E. Abouelmagd, MD	Dr. Abouelmagd has nothing to disclose.
Nereen Almosilhy, MSc , PharmD	Dr. Almosilhy has nothing to disclose.
Ahmed S. Osman	Mr. Osman has nothing to disclose.
Hamdy A. Makhlouf	Mr. Makhlouf has nothing to disclose.
Neha Sudarshan	Miss Sudarshan has nothing to disclose.
Praneeth Anand, MBBS	Dr. Anand has nothing to disclose.
Arihant S. Ghattadahalli, MBBS	Dr. Ghattadahalli has nothing to disclose.
Manasa A. Gowda, MD	Dr. gowda has nothing to disclose.
Emma L. Wetmore, MD	Dr. Wetmore has nothing to disclose.
James N. Brenton, MD, FAAN	Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Diana Lehner-Gulotta, RD	Mrs. Lehner-Gulotta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Formularies.
Claire Har, Jr., MPH	Ms. Har has nothing to disclose.
Ilana L. Kahn, MD	Dr. Kahn has nothing to disclose.
Alyssa Beth Stotz, MS, NBC-HWC	Mrs. Stotz has nothing to disclose.
Lavanya Biju	Ms. Biju has nothing to disclose.
Stella L. Ngo, PhD	Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc.. Dr. Ngo has received personal compensation for serving as an employee of Neurelis Inc..
Liang Zhu	Dr. Zhu has nothing to disclose.
Anna Patten	No disclosure on file
Jocelyn Y. Cheng, MD, FAAN	Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
Eufrosina I. Young, MD	The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Dongliang Wang	Dongliang Wang has nothing to disclose.
George P. Slavinski, Respiratory Therapist	Mr. Slavinski has nothing to disclose.
Dragos Manta	Dragos Manta has nothing to disclose.
Birendra Sah	Birendra Sah has received publishing royalties from a publication relating to health care.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Lena Deb	Lena Deb has nothing to disclose.
Marielle Posmik	Marielle Posmik has nothing to disclose.
Jeffrey P. Collins, RN	Mr. Collins has nothing to disclose.
Emma Blystone, MS	Ms. Blystone has nothing to disclose.
Jenny Meyer, MD	The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Bhavya Narapureddy, MBBS	Dr. Narapureddy has nothing to disclose.
Ahmed Ibrahim, MBBCH	Dr. Ibrahim has nothing to disclose.
Grace Marie N. Dominguez, MD	Dr. Dominguez has nothing to disclose.
Darshana Vijaywargiya, MBBS	Dr. Vijaywargiya has nothing to disclose.
Sara Abdelhafiz, MBBS	Dr. Abdelhafiz has nothing to disclose.
Pradeep Chevula, MD	Dr. Chevula has nothing to disclose.
Takuya Kudo	Mr. Kudo has nothing to disclose.
Kinjal Patel	Kinjal Patel has nothing to disclose.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Travis Zuroske	No disclosure on file
Devon Grochowski	Ms. Grochowski has received personal compensation for serving as an employee of IPM.ai, Real Chemistry.
Shalini Gupta	No disclosure on file
Juan D. Oyola, MD	Dr. Oyola has nothing to disclose.
Mariana Medina, Sr., MD	Dr. Medina has nothing to disclose.
Juan D. Martinez Lemus, MD	Dr. Martinez Lemus has nothing to disclose.
Hugo A. Paez Ardila, Sr., PhD	Dr. Paez Ardila has nothing to disclose.
Claudio A. Monsalve, MD	Mr. Monsalve has nothing to disclose.
Maria I. Reyes, MD	Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Yelizaveta Lysakova, MD	Dr. Lysakova has nothing to disclose.
Krystal Ramsamooj, DO	Dr. Ramsamooj has nothing to disclose.
Andrew M. Zaky, MD	Dr. Zaky has nothing to disclose.
Sara Radmard, MD	Dr. Radmard has nothing to disclose.
Gwen W. Zeigler, DO	Dr. Zeigler has received personal compensation in the range of $0-$499 for serving as a Speaker with American College of Osteopathic Neurologists and Psychiatrists Mid-Year Meeting. Dr. Zeigler has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ��ɫ��. Dr. Zeigler has received personal compensation in the range of $0-$499 for serving as a Speaker with QueerDoc. Dr. Zeigler has received personal compensation in the range of $0-$499 for serving as a Speaker with American Osteopathic Association/Osteopathic Medical ��ɫ�� Conference.
Aman M. Bhonsale, MBBS	Mr. Bhonsale has nothing to disclose.
Vinay Suresh, MBBS	Dr. Suresh has nothing to disclose.
Muneeb Ahmad Muneer	Mr. Muneer has nothing to disclose.
Poorvikha S	Poorvikha S has nothing to disclose.
Malavika Rudrakumar	Miss Rudrakumar has nothing to disclose.
Marium Khan	Marium Khan has nothing to disclose.
Anmol Kaur	Miss Kaur has nothing to disclose.
Mohammad Hassan Bin Ozair, MBBS	Mr. Bin Ozair has nothing to disclose.
Sakshi Sharma, Msc	No disclosure on file
Apoorva Vedula, MBBS	Miss Vedula has nothing to disclose.
Ishita Lanjewar, MBBS	Dr. Lanjewar has nothing to disclose.
Ishita Gupta	Miss Gupta has nothing to disclose.
Kshitij Sonawale, MBBS	Dr. Sonawale has nothing to disclose.
Samantha Blum, DO	Dr. Blum has nothing to disclose.
Callie Rose J. Brown, DO	Dr. Brown has nothing to disclose.
Maria D. Zambrano Espinoza, MD	Dr. Zambrano Espinoza has nothing to disclose.
Jordan Langford, MD	Jordan Langford, MD has nothing to disclose.
Aaron Shoskes, DO	Dr. Shoskes has nothing to disclose.
Karol Budohoski, MD, PhD	Dr. Budohoski has nothing to disclose.
Jennifer J. Majersik, MD, FAAN	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Matthew Doerfler, MD	The institution of Dr. Doerfler has received research support from National MS Society.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Andrew Wolf, MD	The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. The institution of Dr. Wolf has received research support from Genentech. The institution of Dr. Wolf has received research support from Rocky Mountain MS Center. The institution of Dr. Wolf has received research support from Michael J. Fox Foundation. Dr. Wolf has received publishing royalties from a publication relating to health care.
Sufyan Shahid, MBBS	Mr. Shahid has nothing to disclose.
Ayesha Batool, MBBS	Dr. Batool has nothing to disclose.
Abdullah Farooq, MBBS	Mr. Farooq has nothing to disclose.
Advait Teli, MBBS	Dr. Teli has nothing to disclose.
Umna N/A	Miss N/A has nothing to disclose.
Jaffer Shah	Prof. Shah has nothing to disclose.
Syed I. Ali, MBBS	Mr. Ali has nothing to disclose.
Jordan Garris, MD	The institution of Dr. Garris has received research support from Pediatric Epilepsy Research Foundation/Child Neurology Foundation. Dr. Garris has received research support from FNDHope.
Elizabeth Bradley, PhD	Dr. Bradley has nothing to disclose.
Michael Ryan, MD	Dr. Ryan has received publishing royalties from a publication relating to health care.
Elizabeth Snow	Ms. Snow has a non-compensated relationship as a Member of the Research Advisory Committee with FND Hope that is relevant to AAN interests or activities.
Bridget Mildon, Research Manager	Ms. Mildon has received personal compensation in the range of $500-$4,999 for serving as a Expert by Experience Partner with UCL_Centre for Equality Research in Brain Sciences Equality, Diversity and Inclusion. Ms. Mildon has a non-compensated relationship as a Author panel for AAN guideline, Management of Functional Seizures with AAN that is relevant to AAN interests or activities.
Ronald R. Grunstein, MBBS, PhD, FRACP	Prof. Grunstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly . Prof. Grunstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. The institution of Prof. Grunstein has received research support from Alkermes. The institution of Prof. Grunstein has received research support from Eli Lilly.
Brendon Yee, MD, PhD	Prof. Yee has nothing to disclose.
Julia Chapman, PhD	The institution of Dr. Chapman has received research support from American Academy of Sleep Medicine Foundation.
Angela D'Rozario, PhD	The institution of Dr. D'Rozario has received research support from Australian National Health and Medical Research Council. The institution of Dr. D'Rozario has received research support from Australian National Health and Medical Research Council. The institution of Dr. D'Rozario has received research support from Australian National Health and Medical Research Council. The institution of Dr. D'Rozario has received research support from Australian Government Medical Research Future Fund (MRFF) .
Craig Hopkinson, MD	Dr. Hopkinson has received personal compensation for serving as an employee of Alkermes, Inc. An immediate family member of Dr. Hopkinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoRA Consulting LLC. Dr. Hopkinson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Alberio. Dr. Hopkinson has stock in Alkermes, Inc.
Jandira Ramos, MPH	Ms. Ramos has received personal compensation for serving as an employee of Alkermes.
Dan G. Smith, PhD	Dr. Smith has received personal compensation for serving as an employee of Alkermes. Dr. Smith has stock in Alkermes.
Sergey Yagoda, MD, PhD	Dr. Yagoda has received personal compensation for serving as an employee of Alkermes, Inc. Dr. Yagoda has stock in Alkermes, Inc.
Bhaskar Rege	Dr. Rege has received personal compensation for serving as an employee of Alkermes. Dr. Rege has stock in Alkermes. Dr. Rege has received intellectual property interests from a discovery or technology relating to health care.
Lawrence P. Carter, PhD	Dr. Carter has received personal compensation for serving as an employee of Alector. Dr. Carter has stock in Alector. Dr. Carter has stock in Jazz Pharmaceuticals.
Barbara Borroni, MD	Dr. Borroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Borroni has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Catherine Mummery, PhD	Dr. Mummery has nothing to disclose.
Isabelle Le Ber, MD, PhD	Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Therapeutics. Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Megan Smithey, PhD	Dr. Smithey has received personal compensation for serving as an employee of Alector. Dr. Smithey has stock in Alector. Dr. Smithey has stock in Vir Biotechnology. Dr. Smithey has received intellectual property interests from a discovery or technology relating to health care.
Tiffany W. Chow, MD, FAAN	Dr. Chow has received personal compensation for serving as an employee of Alector, Inc.. Dr. Chow has stock in Alector, Inc.. Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on grant U19AG079774 with NIA.
Julie Huang, PhD	Dr. Huang has received personal compensation for serving as an employee of Alector, Inc. Dr. Huang has stock in Alector.
Leonardo Guizzetti, PhD	The institution of Dr. Guizzetti has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Everest Clinical Research.
Giacomo Salvadore, MD	Dr. Salvadore has received personal compensation for serving as an employee of Alector, Inc. Dr. Salvadore has stock in Alector, Inc..
Gary J. Romano, MD, PhD	Dr. Romano has received personal compensation for serving as an employee of Alector. Dr. Romano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALector. Dr. Romano has or had stock in Alector.
Sushuma Yarlagadda, MD	Dr. Yarlagadda has nothing to disclose.
Osman Corbali, MD	Mr. Corbali has nothing to disclose.
Julien Cavanagh, MD	Dr. Cavanagh has nothing to disclose.
Mithilesh Siddu, MD	Dr. Siddu has nothing to disclose.
Spencer Hutto, MD	Dr. Hutto has nothing to disclose.
James Greene, MD, PhD	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Samantha Brown, MD	Ms. Brown has nothing to disclose.
Alexandria C. Vernon, PA	Ms. Vernon has received personal compensation for serving as an employee of CND Life Sciences .
Mariah Schroeder	Ms. Schroeder has nothing to disclose.
Brenna C. Beezhold	Ms. Beezhold has nothing to disclose.
Tony Luehrs, MS	Mr. Luehrs has nothing to disclose.
Hugues Sicotte, PhD	An immediate family member of Dr. Sicotte has stock in Fastenal.
Robert Vierkant, MS	Mr. Vierkant has nothing to disclose.
William A. Libling	Mr. Libling has nothing to disclose.
Jan Egan, PhD	Dr. Egan has nothing to disclose.
Konstantinos Lazaridis	No disclosure on file
Gyanendra Kumar, MD, FAAN	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Santiago Clocchiatti-Tuozzo	Mr. Clocchiatti-Tuozzo has nothing to disclose.
Cyprien Rivier, MD	Dr. Rivier has nothing to disclose.
Shufan Huo, MD, PhD	Dr. Huo has nothing to disclose.
Ashkan Shoamanesh, MD	Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer AG. Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo . Dr. Shoamanesh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier Inc.. Dr. Shoamanesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurodiem.ca. The institution of Dr. Shoamanesh has received research support from Servier Canada Inc.. The institution of Dr. Shoamanesh has received research support from Daiichi Sankyo Ltd.. The institution of Dr. Shoamanesh has received research support from Bayer AG. The institution of Dr. Shoamanesh has received research support from Bristol-Myers Squibb. The institution of Dr. Shoamanesh has received research support from Octapharma Canada .
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Thomas Gill	Thomas Gill has nothing to disclose.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Rogelio Dominguez-Moreno, MD	Dr. Dominguez-Moreno has nothing to disclose.
Agnies van Eeghen, PhD	The institution of Dr. van Eeghen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals . The institution of Dr. van Eeghen has received research support from jazz pharmaceuticals . The institution of Dr. van Eeghen has received research support from ForWishdoem . The institution of Dr. van Eeghen has received research support from European Commission / ERN ITHACA .
Sarah L. Wilson, MD	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.
Douglas M. Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pyros Pharma. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Jane Boggs, MD	The institution of Dr. Boggs has received research support from Liva Nova. Dr. Boggs has a non-compensated relationship as a Chairman PAB with Epilepsy Alliance North Carolina that is relevant to AAN interests or activities.
Teresa Greco	Teresa Greco has nothing to disclose.
Joanne Stevens, BA	Ms. Stevens has stock in Jazz Pharmaceuticals.
Lisa Moore-Ramdin, MBBS	Dr. Moore-Ramdin has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Moore-Ramdin has stock in Jazz Pharmaceuticals.
Heitor Cabral Frade, MD	Dr. Cabral Frade has nothing to disclose.
Aabishkar Bhattarai, MD	Dr. Bhattarai has nothing to disclose.
Laura J. Wu, MD, PhD	Dr. Wu has nothing to disclose.
Diosely C. Silveira, MD, PhD, FAAN	Dr. Silveira has nothing to disclose.
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Jelena Drulovic	Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PharmaSwiss. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actavis TEVA. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis. Jelena Drulovic has received research support from Ministry of Science, Technological Development and Innovations of the Republic of Serbia.
Michal Dufek, PhD	Dr. Dufek has nothing to disclose.
Hrvoje Budincevic	The institution of Hrvoje Budincevic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viatris. The institution of Hrvoje Budincevic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Hrvoje Budincevic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis Adria. The institution of Hrvoje Budincevic has received research support from F. Hoffmann-La Roche Ltd. The institution of Hrvoje Budincevic has received research support from NovoNordisk. The institution of Hrvoje Budincevic has received research support from Celltrion.
Mario Habek	Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Mario Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. An immediate family member of Mario Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Mario Habek has received research support from Croatian Science Foundation.
Maresa Caunt	Mrs. Caunt has received personal compensation for serving as an employee of Genentech. Mrs. Caunt has stock in Genentech.
Malgorzata Sierzega	Malgorzata Sierzega has stock in Roche.
David Clayton	David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
YING-FANG CHEN, PhD	Dr. CHEN has nothing to disclose.
John Ratchford, MD	Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Alexandra L. Goodyear, MD	Dr. Goodyear has received personal compensation for serving as an employee of Genentech. Dr. Goodyear has received personal compensation for serving as an employee of Novartis. Dr. Goodyear has stock in Novartis. Dr. Goodyear has stock in Genentech.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Andrew Silverman, MD	Dr. Silverman has nothing to disclose.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Katherine Thomas, MD	Dr. Thomas has nothing to disclose.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Tom LaRocca, MD, PhD	Dr. LaRocca has nothing to disclose.
Priya Nigam, MD	Miss Nigam has nothing to disclose.
Kaitlyn Naughton, Student	Miss Naughton has nothing to disclose.
Valeria Castro-Ariza	Ms. Castro-Ariza has nothing to disclose.
Nadia Mansoor	Ms. Mansoor has nothing to disclose.
Latoya Weaver, Clinical Concierge Coordinator	Ms. Weaver has nothing to disclose.
Luisa I. Enriquez, Social Worker	Miss Enriquez has nothing to disclose.
Molly C. Cincotta, MD	Dr. Cincotta has nothing to disclose.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Pooja Jethwani, MBBS	Ms. Jethwani has nothing to disclose.
Anvesh Balabhadra, MBBS	Dr. Balabhadra has nothing to disclose.
Karan Tarasaria, MBBS	Dr. Tarasaria has nothing to disclose.
Amita Bose	Ms. Bose has nothing to disclose.
Gabriela Figueiredo Pucci, MD	Dr. Figueiredo Pucci has nothing to disclose.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Casey S. Albin, MD, FAAN	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from ��ɫ��. Dr. Albin has received publishing royalties from a publication relating to health care.
Luis A. Marin-Castañeda, Sr.	Mr. Marin-Castañeda has nothing to disclose.
Amairany Vidal	No disclosure on file
Jimena Gonzalez Salido, MD	Miss Gonzalez Salido has nothing to disclose.
Gerson Angel Alavez	No disclosure on file
Geronimo Pacheco Aispuro, Sr., MD, PhD	Dr. Pacheco Aispuro has nothing to disclose.
Antonio de León	No disclosure on file
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Bruce C. Corser, MD	Dr. Corser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. Dr. Corser has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Avadel. The institution of Dr. Corser has received research support from Alkermes, . The institution of Dr. Corser has received research support from Apnimed. The institution of Dr. Corser has received research support from Avadel. The institution of Dr. Corser has received research support from Axsome. The institution of Dr. Corser has received research support from Eisai. The institution of Dr. Corser has received research support from Eli Lilly. The institution of Dr. Corser has received research support from Harmony. The institution of Dr. Corser has received research support from Incannex. The institution of Dr. Corser has received research support from Jazz. The institution of Dr. Corser has received research support from Mineralys. The institution of Dr. Corser has received research support from Suven. The institution of Dr. Corser has received research support from Takeda. The institution of Dr. Corser has received research support from Centessa.
Akinyemi Ajayi, MD	Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz pharmaceuticals. Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for avadel. Dr. Ajayi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for harmony biosciences. Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jazz pharmaceuticals. Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for avadel . Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for jazz pharmaceuticals. Dr. Ajayi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for avadel. Dr. Ajayi has stock in avadel.
Brian Abaluck, MD	Dr. Abaluck has received personal compensation for serving as an employee of Avadel Pharmaceuticals.
Jennifer Gudeman	Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.
Michael Kahana, PhD	Prof. Kahana has stock in Nia Therapeutics. Prof. Kahana has received intellectual property interests from a discovery or technology relating to health care.
Daniel Rizzuto, PhD	Dr. Rizzuto has received personal compensation for serving as an employee of Nia Therapeutics. Dr. Rizzuto has stock in Nia Therapeutics. Dr. Rizzuto has received intellectual property interests from a discovery or technology relating to health care.
Brinda Desai, MBBS	Dr. Desai has nothing to disclose.
Bhargav Makwana, MD	Mr. Makwana has nothing to disclose.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN	Dr. Srinivasan has nothing to disclose.
Diana Apetauerova, MD	Dr. Apetauerova has nothing to disclose.
Sourbha S. Dani, MD	Dr. Dani has nothing to disclose.
Siddharth Sehgal, MD	Dr. Sehgal has nothing to disclose.
Oleg Y. Yerstein, MD	Dr. Yerstein has nothing to disclose.
Sumanth Khadke, MD	Dr. Khadke has nothing to disclose.
Ashish Kumar, MBBS	Dr. Kumar has nothing to disclose.
Khurram Nasir	No disclosure on file
Rishi Wadhera, MD	Dr. Wadhera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chamerbcardio. Dr. Wadhera has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Wadhera has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HSR Journal.
Yixin Kong, PhD	Dr. Kong has nothing to disclose.
Ana Navas-Acien	No disclosure on file
Gary Adamkiewicz	No disclosure on file
sanjay rajagopalan, MD	No disclosure on file
Sadeer G. Al-Kindi, MD	Dr. Al-Kindi has nothing to disclose.
Susan D. Moffatt-Bruce, MD	Dr. Moffatt-Bruce has nothing to disclose.
Sarju Ganatra, MD	Dr. Ganatra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Ganatra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Humana.
Taizen Nakase	Taizen Nakase has nothing to disclose.
Kenji Honkura, MD, PhD	Dr. Honkura has nothing to disclose.
Rie Ono, MD	Dr. Ono has nothing to disclose.
Yasuko Tatewaki, MD, PhD	Dr. Tatewaki has nothing to disclose.
Yumi Takano, PhD	Dr. Takano has nothing to disclose.
Shuko Nomura, MD	Dr. Nomura has nothing to disclose.
Hae Woon Baek, MD	Dr. Baek has nothing to disclose.
Yasuyuki Taki, MD, PhD	Prof. Taki has nothing to disclose.
Shin Takayama	No disclosure on file
Sergio Baranzini	Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Salah Foundation. The institution of Sergio Baranzini has received research support from NIH. The institution of Sergio Baranzini has received research support from NSF. Sergio Baranzini has received intellectual property interests from a discovery or technology relating to health care. Sergio Baranzini has a non-compensated relationship as a co-funder with Mate Bioservices that is relevant to AAN interests or activities.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Gabriel A. Cerono	Dr. Cerono has nothing to disclose.
Golnoush Akhlaghipour, MD	Dr. Akhlaghipour has nothing to disclose.
Gautham V. Upadrasta, MD	Dr. Upadrasta has nothing to disclose.
Johanna Seiden, MD	Dr. Seiden has nothing to disclose.
Jayant K. Yadav, MD	Dr. Yadav has nothing to disclose.
Wenzheng Yu, MD	Dr. Yu has nothing to disclose.
Razaz Mageid, MD	Ms. Mageid has nothing to disclose.
Riccardo Serra, MD	No disclosure on file
Prajwal Ciryam, MD, PhD	The institution of Dr. Ciryam has received research support from Henry M. Jackson Foundation. The institution of Dr. Ciryam has received research support from Passano Foundation. The institution of Dr. Ciryam has received research support from GEn1E Lifesciences. The institution of Dr. Ciryam has received research support from Brain Aneurysm Foundation. The institution of Dr. Ciryam has received research support from Neurocritical Care Foundation. The institution of Dr. Ciryam has received research support from Center for Shock, Trauma, and Anesthesiology Research, University of Maryland.
J. Marc Simard, MD, PhD	Dr. Simard has nothing to disclose.
Vladimir Gerzanich, MD, PhD	The institution of Dr. Gerzanich has received research support from NIH.
Brad Wilhelmy	Mr. Wilhelmy has nothing to disclose.
Bosung Shim, MS	Mr. Shim has nothing to disclose.
Deap S. Bhandal	Mr. Bhandal has received research support from Health Resources and Services Administration.
Justin Tuschhoff	Mr. Tuschhoff has received research support from Health Resources and Services Administration.
Devin M. Davies	Mr. Davies has received research support from Health Resources and Services Administration.
Chris S. Colwell, PhD	Prof. Colwell has nothing to disclose.
Cristina A. Ghiani, PhD	Dr. Ghiani has nothing to disclose.
Kyle Nguyen-Ngo	Mr. Nguyen-Ngo has nothing to disclose.
Louis Ferrari	No disclosure on file
Zhen Hong	Prof. Hong has nothing to disclose.
Kensuke Kawai, MD, PhD	Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Biopharma. Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Japan. Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zimmer Biomet. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EP Medical. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Daiichi-Sankyo.
Sunita N. Misra, MD	Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Peimin Yu	Dr. Yu has nothing to disclose.
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Karlos Daniell A. dos Santos, Sr., Medical student	Mr. dos Santos has nothing to disclose.
Filipi F. Andreão	Mr. Andreão has nothing to disclose.
Filipe V. Ribeiro, MD	Ms. Ribeiro has nothing to disclose.
Carolina B. Moura, MD	Dr. Moura has nothing to disclose.
Diogo Haddad Santos, MD	Dr. Haddad Santos has nothing to disclose.
Fernanda Herculano, MD	Dr. Herculano has nothing to disclose.
Sanjit K. Sah, MD	Dr. Sah has nothing to disclose.
Ai Sakonju, MD	Dr. Sakonju has nothing to disclose.
Jorge E. Patino Murillas, MD	Dr. Patino Murillas has nothing to disclose.
Vedang Vyas, MBBS	Dr. Vyas has nothing to disclose.
Yasuhiko Matsumori, Jr., MD, PhD	Dr. Matsumori has nothing to disclose.
Koichi Ikeda, MD	Mr. Ikeda has nothing to disclose.
Masako Kudo, MD	Dr. Kudo has nothing to disclose.
Tomofumi Ishikawa, PhD	Dr. Ishikawa has received personal compensation for serving as an employee of Pfizer. Dr. Ishikawa has stock in Pfizer.
Yuko Hoshino, PhD	Dr. Hoshino has received personal compensation for serving as an employee of Pfizer.
Hiroki Yoshimatsu, PhD	Dr. Yoshimatsu has received personal compensation for serving as an employee of Pfizer R&D Japan.
Alexandra Thiry, PhD	Dr. Thiry has received personal compensation for serving as an employee of Pfizer. Dr. Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Thiry has stock in Pfizer. Dr. Thiry has stock in Biohaven Pharmaceuticals.
Akio Arakawa, PhD	Dr. Arakawa has received personal compensation for serving as an employee of Pfizer. Dr. Arakawa has stock in Pfizer.
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Terence Fullerton, PharmD	Dr. Fullerton has received personal compensation for serving as an employee of Pfizer. Dr. Fullerton has stock in Pfizer.
Fumihiko Sakai, MD	Dr. Sakai has nothing to disclose.
TAKAO Takeshima	Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sawai. Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teijin. Dr. Takeshima has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hedgcock MedTech. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Elli-Lilly Japan. The institution of Dr. Takeshima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi-Sankyo.
Saba Jafarpour, MD	Dr. Jafarpour has nothing to disclose.
Panteha Hayati Rezvan, PhD	Dr. Hayati Rezvan has nothing to disclose.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Natalie Boyd	Natalie Boyd has nothing to disclose.
Benjamin Vogel	Benjamin Vogel has nothing to disclose.
Lina Nguyen	Lina Nguyen has nothing to disclose.
Lilia Kazerooni, BS	Miss Kazerooni has nothing to disclose.
Noemi Spinazzi, MD	Dr. Spinazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Spinazzi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Saldivar & Associates. The institution of Dr. Spinazzi has received research support from NIH.
Nidhiben A. Anadani, MD	Dr. Anadani has nothing to disclose.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Robyn A. Filipink, MD	The institution of an immediate family member of Dr. Filipink has received research support from NIH . Dr. Filipink has received personal compensation in the range of $0-$499 for serving as a Author with Medlink.
Melanie Manning	Melanie Manning has nothing to disclose.
Catherine Franklin	Catherine Franklin has nothing to disclose.
Eileen Quinn, MD	Dr. Quinn has nothing to disclose.
Michael S. Rafii, MD, PhD	Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Dana Ghazaleh, MD	Dr. Ghazaleh has nothing to disclose.
Omair Ul Haq Lodhi, MBBS	Dr. Lodhi has nothing to disclose.
Allison M. Ho, MD	Ms. Ho has nothing to disclose.
Edward Labin, MD	Dr. Labin has nothing to disclose.
Jessica H. Goldstein, MD, FAAN	Dr. Goldstein has nothing to disclose.
Abhiram Parameswaran, MBBS	Dr. Parameswaran has nothing to disclose.
Amit Ray, MD, FAAN	Dr. Ray has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Ray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Ray has or had stock in Harmony Biosciences.
George G. Nomikos, MD, PhD	Dr. Nomikos has received personal compensation for serving as an employee of Harmony Biosciences.
Grant Runyan, PhD	Mr. Runyan has received personal compensation for serving as an employee of Harmony Biosciences. Mr. Runyan has stock in Harmony Biosciences.
Juby Philip	Mrs. Philip has nothing to disclose.
David Albers, PhD	Dr. Albers has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Albers has or had stock in Harmony Biosciences.
Scott C. Baraban, PhD	Prof. Baraban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences.
Kumar Budur, MD	Kumar Budur, MD has received personal compensation for serving as an employee of Harmony Biosciences. Kumar Budur, MD has stock in Abbvie.
Lina Al Qadi	Miss Al Qadi has nothing to disclose.
Josiane Stadler	Ms. Stadler has nothing to disclose.
Dominique Comeau	Dominique Comeau has nothing to disclose.
Véronique Landry, MD	Dr. Landry has received personal compensation in the range of $50,000-$99,999 for serving as a Trainee in the Royal College of Physicians and Surgeons of Canada : Clinicial-Investigator Program with Vitalité Health Network.
Mahée Cote, Medical Student	Miss Cote has nothing to disclose.
Marie-Claire Losier, DPs, LPsych	Dr. Losier has nothing to disclose.
Emilie Laplante, PsyD	Dr. Laplante has nothing to disclose.
Gilles A. Robichaud, PhD	Prof. Robichaud has stock in Agrogene solutions Inc . The institution of Prof. Robichaud has received research support from Canadian cancer society .
Luc Boudreau, PhD	Dr. Boudreau has nothing to disclose.
Robert Laforce, Jr., MD, PhD	Dr. Laforce has nothing to disclose.
Ludivine Chamard Witkowski	Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ludivine Chamard Witkowski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck Serono. The institution of Ludivine Chamard Witkowski has received research support from CFMNB. The institution of Ludivine Chamard Witkowski has received research support from Cantrain.
Patricio Castro Suarez	Mr. Castro Suarez has nothing to disclose.
Claudia Cruzalegui Bazán	Miss Cruzalegui Bazán has nothing to disclose.
Lucero del Pilar Peltroche Ramos, MS	Miss Peltroche Ramos has nothing to disclose.
Kevin S. Capra Sanabria	Dr. Capra Sanabria has nothing to disclose.
Carlos Rodrigo Q. Vicuña	Mr. Vicuña has nothing to disclose.
Rachel E. Dum, MD	Mrs. Dum has nothing to disclose.
James Grogan, MD	Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Katrina Bakhl	Miss Bakhl has nothing to disclose.
Angela Sohng	Miss Sohng has nothing to disclose.
Sanford H. Auerbach, MD, FAAN	Dr. Auerbach has nothing to disclose.
Jai G. Marathe, MBBS	The institution of Dr. Marathe has received research support from NIH.
Michael Alosco, PhD	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Shruti Misra	Ms. Misra has nothing to disclose.
Andrew Tsao, BS	Mr. Tsao has nothing to disclose.
Ariana Rauch, BA	Miss Rauch has nothing to disclose.
Ta'Kiya Moore	Miss Moore has nothing to disclose.
Neoreet Braha	Ms. Braha has nothing to disclose.
Karmveer Kaur	Ms. Kaur has nothing to disclose.
Jim Varghese, Medical Student	Mr. Varghese has nothing to disclose.
Fawad A. Khan, MD	The institution of Dr. Khan has received research support from Amgen .
Amanda K. Dalrymple	Mrs. Dalrymple has nothing to disclose.
Abdullah Syed	Mr. Syed has nothing to disclose.
Johanne M. Kaplan, PhD	Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Scott Napper, PhD	The institution of Dr. Napper has received research support from NSERC. The institution of Dr. Napper has received research support from Westin Foundation.
Ebrima Gibbs, Bsc, BMLSc, MSc	Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Erin Scruten, Research Technician	Ms. Scruten has nothing to disclose.
Juliane Coutts	Ms. Coutts has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ProMIS Neurosciences, Inc..
Joel Watts	The institution of Dr. Watts has received research support from Canadian Institutes of Health Research. The institution of Dr. Watts has received research support from Weston Family Foundation.
Marco A. Prado, PhD	Dr. Prado has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurochemistry. The institution of Dr. Prado has received research support from CIHR. The institution of Dr. Prado has received research support from Alzheimer's Association. The institution of Dr. Prado has received research support from Weston Family Foundation. The institution of Dr. Prado has received research support from NFRF. The institution of Dr. Prado has received research support from NSERC.
Neil Cashman, MD	Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.
Shige Kitamura, MD	Dr. ?? has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. ?? has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Otsuka. Dr. ?? has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. ?? has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. ?? has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Toshimasa Yamamoto, MD, PhD	Dr. Yamamoto has nothing to disclose.
Anvi Kumar	Ms. Kumar has nothing to disclose.
Minali Tare	Ms. Tare has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Vicki Fung	An immediate family member of Vicki Fung has received personal compensation for serving as an employee of Vertex Pharmaceuticals. An immediate family member of Vicki Fung has stock in Vertex Pharmaceuticals. The institution of Vicki Fung has received research support from NIH. The institution of Vicki Fung has received research support from AHRQ. The institution of Vicki Fung has received research support from Google LLC.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Omar J. Alomari	Mr. Alomari has nothing to disclose.
Mohammed A. Al-kurdi, MD	Dr. Al-kurdi has nothing to disclose.
Lobna Ahmed Mohamed	Dr. Ahmed Mohamed has nothing to disclose.
Mohamed M. Ghonaim, MBBS	Dr. Ghonaim has nothing to disclose.
Ahmed W. Fathy II, MD	Dr. Fathy has nothing to disclose.
Hazem K. Hassaan, MD	Dr. Hassaan has nothing to disclose.
Ahmed Anan, MD	Dr. Anan has nothing to disclose.
Nagham N. Abdelhalim, MD	Miss Abdelhalim has nothing to disclose.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Alen Delic	Alen Delic has nothing to disclose.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Tammy L. Smith, MD, PhD	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Batool A. Hussain, MD, MBBS	Dr. Hussain has nothing to disclose.
Jeffrey D. Kennedy, MD	Dr. Kennedy has nothing to disclose.
Kiran M. Kanth, MD	Dr. Kanth has nothing to disclose.
Shubhi Agrawal, MD	Dr. Agrawal has nothing to disclose.
Srishti Rajeev	Ms. Rajeev has nothing to disclose.
Jordan A. Killion, PhD	Dr. Killion has received personal compensation for serving as an employee of CommonSpirit Health. The institution of Dr. Killion has received research support from The Michael J. Fox Foundation for Parkinson's Research (MJFF-000939). The institution of Dr. Killion has received research support from Department of Defense Grant (PD190057). The institution of Dr. Killion has received research support from Barrow Neurological Foundation. The institution of Dr. Killion has received research support from Kemper and Ethel Marley Foundation. The institution of Dr. Killion has received research support from Moreno Family.
Irene Faust, MPH	Ms. Faust has nothing to disclose.
Sai Anmisha Doddamreddy, MS	Miss Doddamreddy has nothing to disclose.
Brittany Krzyzanowski, PhD	Dr. Krzyzanowski has nothing to disclose.
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Brad A. Racette, MD, FAAN	Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Ishani Khatiwala, MD	Dr. Khatiwala has nothing to disclose.
Sanket Aggarwal, MD	Mr. Aggarwal has nothing to disclose.
Shital Patel, MD	Dr. Patel has nothing to disclose.
Andrew J. Lee, MD	Dr. Lee has nothing to disclose.
Sai P. Polineni, MD	Dr. Polineni has nothing to disclose.
Angela T. Kwan, MSc	Miss Kwan has nothing to disclose.
Ziji Guo	Ziji Guo has nothing to disclose.
Felicia Ceban	Felicia Ceban has nothing to disclose.
Kayla Teopiz	Kayla Teopiz has received personal compensation in the range of $10,000-$49,999 for serving as a Contractor with Braxia Scientific Corp. Kayla Teopiz has received personal compensation in the range of $500-$4,999 for serving as a Contractor with Brain and Cognition Discovery Foundation.
Greg Rhee, PhD	Prof. Rhee has nothing to disclose.
Ho C. Man, MD	Prof. Man has nothing to disclose.
Sebastian Badulescu	Sebastian Badulescu has nothing to disclose.
Shakila Meshkat, MD	Dr. Meshkat has nothing to disclose.
Bing Cao, PhD	Dr. Cao has nothing to disclose.
Joshua Rosenblat	Joshua Rosenblat has nothing to disclose.
Donovan Dev, Student	Mr. Dev has nothing to disclose.
Lee Phan	Lee Phan has nothing to disclose.
Roger McIntyre	Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Atai Life Sciences. Roger McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Research Grant Support with CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute.
Wdasie Ayele, student	Ms. Ayele has nothing to disclose.
Jessica Hemm	Mrs. Hemm has received personal compensation for serving as an employee of Rush Medical Center.
Evelyn Stevens, MPH	Miss Stevens has received personal compensation for serving as an employee of Parkinson's Foundation.
Sarah M. Chen, LCSW	Ms. Chen has nothing to disclose.
Elizabeth C. Rachchh	Mrs. Rachchh has received personal compensation for serving as an employee of Lewy Body Dementia Association.
Angela Taylor	Mrs. Taylor has received personal compensation for serving as an employee of Lewy Body Dementia Association.
Keith N. Fargo, PhD	An immediate family member of Dr. Fargo has received personal compensation for serving as an employee of Parexel. Dr. Fargo has received personal compensation for serving as an employee of Lewy Body Dementia Association. Dr. Fargo has received personal compensation for serving as an employee of CMT Research Foundation.
Diane Mariani, LCSW	Ms. Mariani has nothing to disclose.
Sandhya Seshadri, PhD	The institution of Dr. Seshadri has received research support from NIH.
Cintra Bentley, Esq	Ms. Bentley has received personal compensation in the range of $5,000-$9,999 for serving as a Member of LBD Advisory Panel with Rush University Medical Center.
Thomas J. Manak	Mr. Manak has received personal compensation in the range of $0-$499 for serving as a Advisory Board Member with NIH.
Allegra Miller, volunteer	Ms. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Caregiver Advisory Panel for Persevere with NIH.
Claire E. Pensyl, MA, JD	Ms. Pensyl has nothing to disclose.
Carmen Pierce	Mrs. Pierce has received personal compensation in the range of $0-$499 for serving as a Advisory Member with NIH.
Margaret Voss, Co author	Ms. Voss has received personal compensation in the range of $5,000-$9,999 for serving as a LBD ADVISORY PANEL MEMBER with RUSH UNIVERSITY MEDICAL CENTER.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Joshua Chodosh, MD	The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Weijing Tang, PhD	Dr. Tang has nothing to disclose.
Wen Zhu, MD	Dr. Zhu has nothing to disclose.
Zongqi Xia, MD, PhD	The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.
Tianxi Cai	Tianxi Cai has nothing to disclose.
James D. DiSanto, MSc	Mr. DiSanto has nothing to disclose.
Natasha Khan, MD	Dr. Khan has nothing to disclose.
Mackenzie Paller-Moore, MD	An immediate family member of Dr. Paller-Moore has received personal compensation for serving as an employee of Waymo. An immediate family member of Dr. Paller-Moore has received personal compensation for serving as an employee of Google. An immediate family member of Dr. Paller-Moore has stock in Google. Dr. Paller-Moore has stock in Mutual Funds. An immediate family member of Dr. Paller-Moore has stock in Mutual Funds.
Katelynn Getchell, MD	Dr. Getchell has nothing to disclose.
Rizwan Kalani, MD	The institution of Dr. Kalani has received research support from NIH.
Vivian Yang, MD	Dr. Yang has nothing to disclose.
Emanuele Camerucci, MD	Dr. Camerucci has nothing to disclose.
Tuqa Asedi, MD	Dr. Asedi has nothing to disclose.
Chelsey M. Schartz	Ms. Schartz has nothing to disclose.
Hussein Alsadi	Hussein Alsadi has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD	Dr. Al-Sabbagh has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Dina M. Al-Nuaimi, MD	Miss Al-Nuaimi has nothing to disclose.
Alyssa M. Kim	Ms. Kim has nothing to disclose.
Emily Koenig, BA	Ms. Koenig has nothing to disclose.
Tiffany Harmanian, Medical Student	Ms. Harmanian has nothing to disclose.
Rexhina Ago	Miss Ago has nothing to disclose.
Matthew Dinh	Mr. Dinh has nothing to disclose.
Asim Roy, MD	Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Bioscience. The institution of Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Inspire. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Inspire. The institution of Dr. Roy has received research support from Jazz . The institution of Dr. Roy has received research support from Inspire. The institution of Dr. Roy has received research support from Avadel.
John D. Hudson, MD, FAAN	Dr. Hudson has nothing to disclose.
Adrian A. Santamaria, MD	Dr. Santamaria has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avadel,. Dr. Santamaria has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz . Dr. Santamaria has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel. Dr. Santamaria has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz .
Nikolas Georgakis, BS	Mr. Georgakis has nothing to disclose.
Sakina Matcheswalla, MBBS	Dr. Matcheswalla has nothing to disclose.
Sarah E. Muir, BSA, BA	Ms. Muir has nothing to disclose.
Jeffrey M. Griffin	Mr. Griffin has nothing to disclose.
Abhishek Vyas	Mr. Vyas has nothing to disclose.
Nithisha Thatikonda, MBBS	Dr. Thatikonda has nothing to disclose.
Xiangping Li, MD, FAAN	Dr. Li has nothing to disclose.
Christine de la Loge	The institution of Mrs. de la Loge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for UCB.
Sami Elmoufti, MBBS	Dr. Elmoufti has nothing to disclose.
Jan-Peer Elshoff, PhD	Dr. Elshoff has nothing to disclose.
Brian D. Moseley, MD	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Kristy L. Pucylowski, PharmD	Dr. Pucylowski has received personal compensation for serving as an employee of UCB, Inc.. Dr. Pucylowski has stock in UCB, Inc..
Dimitrios Bourikas	Dr. Bourikas has nothing to disclose.
Jessica E. Decker, DO	Dr. Decker has nothing to disclose.
Ezequiel Gleichgerrcht, MD	Dr. Gleichgerrcht has nothing to disclose.
Nynoshka M. Bassatt Cabrera, MD	Dr. Bassatt Cabrera has nothing to disclose.
Sara T. Ali, MD	Dr. Ali has nothing to disclose.
Aditi Anam	Ms. Anam has nothing to disclose.
Melisha Budhathoki, MD	Dr. Budhathoki has nothing to disclose.
Priya Narwal, MD	Dr. Narwal has nothing to disclose.
Mahmoud A. Almady, MD	Mr. Almady has nothing to disclose.
John C. Novak, MD	Dr. Novak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MT Pharma America. Dr. Novak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ALS Association. Dr. Novak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Novak has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Novak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT Pharma. The institution of Dr. Novak has received research support from ALS Association. Dr. Novak has received research support from MT Pharma.
Malgorzata Ciepielewska	Malgorzata Ciepielewska has received personal compensation for serving as an employee of Mitsubishi Tanable Pharma America, Inc..
Jeffrey Zhang	The institution of Jeffrey Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioVie.
Ying Liu	Ying Liu has nothing to disclose.
Polina Da Silva, Other	Mrs. Da Silva has nothing to disclose.
Mohammad T. Abuawwad	Dr. Abuawwad has nothing to disclose.
Mohammad Jehad J. Taha	Dr. Taha has nothing to disclose.
Ahmad Taha, Jr., MD	Dr. Taha has nothing to disclose.
Yasmeena A. Kozaa, MBBS	Dr. kozaa has nothing to disclose.
OBAIDA Falah, Mbbch	Dr. Falah has nothing to disclose.
Ibrahim Abuawwad, MD	Mr. Abuawwad has nothing to disclose.
Elsayed M. Hammad, MBBS	Dr. Hammad has nothing to disclose.
Mohammad Aladawi, MD	Dr. Aladawi has nothing to disclose.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Manjit Matharu	The institution of Manjit Matharu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Manjit Matharu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. The institution of Manjit Matharu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. The institution of Manjit Matharu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Manjit Matharu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Manjit Matharu has received research support from Abbott. The institution of Manjit Matharu has received research support from EDS Society. The institution of Manjit Matharu has received research support from Medtronic. Manjit Matharu has received intellectual property interests from a discovery or technology relating to health care.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Pranav Gandhi	Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Brett Dabruzzo, PharmD	Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Winnie Liu	Ms. Liu has nothing to disclose.
Caroline Cerilli	Ms. Cerilli has nothing to disclose.
Lourdes Carhuapoma, PhD, NP	Dr. Carhuapoma has nothing to disclose.
Bonnielin Swenor, PhD	The institution of Dr. Swenor has received research support from NIH. Dr. Swenor has received personal compensation in the range of $500-$4,999 for serving as a presenter and/or expert advisor with AHRQ, American Chemical Society, Boston Childrens, IVI, Urban Institute, Macy Foundation, NORC.
Susanne Muehlschlegel, MD, MPH, FAAN	Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with ��ɫ��. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Ahmed S. Almezaine, MD	Dr. Almezaine has nothing to disclose.
Abdallah Elkhouly, MBBS	Dr. Elkhouly has nothing to disclose.
Gregor Fistravec, Other	Mr. Fistravec has received personal compensation for serving as an employee of IMPULS , nadacní fond.
Dominika Stastna, MD, PhD	Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Stastna has received publishing royalties from a publication relating to health care.
Jiri Drahota, MSc	Jiri Drahota has received personal compensation for serving as an employee of IMPULS Endowment Fund. Jiri Drahota has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche s.r.o.. Jiri Drahota has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis s.r.o..
Pavel Potuznik	Pavel Potuznik has nothing to disclose.
Radek Ampapa, MD	Dr. Ampapa has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Ampapa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzym. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Jana Houskova, MD	Mrs. Houskova has nothing to disclose.
Jana Libertinova	Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck Serono. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Mayer Squibb. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva.
Alena Martinkova, MD	Dr. Martinkova has nothing to disclose.
Zbyšek Pavelek, MD	Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for bristol myers squibb. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
Marek Peterka	Marek Peterka has nothing to disclose.
Eva Recmanova, MD	Dr. Recmanova has nothing to disclose.
Zuzana Rous, PhD	Dr. Rous has nothing to disclose.
Ivana Stetkarova, MD, PhD	Ivana Stetkarova, MD, PhD has nothing to disclose.
Pavel Stourac, MD	Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol- Myers Squibb. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis .
Marta Vachova, MD	Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Ivana Woznicova, MD	Dr. Woznicova has nothing to disclose.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Marketa Grunermelova, MD	Dr. Grunermelova has nothing to disclose.
Ingrid Menkyova	Ingrid Menkyova has nothing to disclose.
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Julia Cho	Ms. Cho has nothing to disclose.
Marinos G. Sotiropoulos, MD	Dr. Sotiropoulos has or had stock in Moderna.Dr. Sotiropoulos has or had stock in Ikena Oncology.Dr. Sotiropoulos has or had stock in Cassava Sciences.Dr. Sotiropoulos has or had stock in Biogen.Dr. Sotiropoulos has or had stock in Tiziana Life Sciences.Dr. Sotiropoulos has received publishing royalties from a publication relating to health care.
Tamara B. Kaplan, MD, FAAN	Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
DANIELA URMA, MD	Mrs. URMA has nothing to disclose.
Janette Bow-Keola	Miss Bow-Keola has nothing to disclose.
Daniel Vodak	Mr. Vodak has nothing to disclose.
Kai Y. Moriyama, Undergraduate Student	Mr. Moriyama has nothing to disclose.
Yun Shwe-kya Pine, Student	Miss Pine has nothing to disclose.
Kylie C. Yamauchi	Ms. Yamauchi has nothing to disclose.
Michael Read, MD student	Mr. Read has nothing to disclose.
Shay Nakahira	Ms. Nakahira has nothing to disclose.
Kirra Borrello	Miss Borrello has nothing to disclose.
D-Dré Wright	Ms. Wright has nothing to disclose.
Anita Cheung, MPH	Miss Cheung has nothing to disclose.
Ryan Nakamura	Mr. Nakamura has received personal compensation for serving as an employee of Hawaii Health & Harm Reduction Center.
Chris K. Deng	Mr. Deng has nothing to disclose.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Kore K. Liow, MD, FACP	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Amir H. Meghdadi, PhD	Dr. Meghdadi has received personal compensation for serving as an employee of Advanced Brain Monitoring. The institution of Dr. Meghdadi has received research support from National Institute of Health (NIH).
Fritz F. Vascones Roman, Sr.	Mr. Vascones Roman has nothing to disclose.
Brigith R. Avila Lucas, Sr., MD	Dr. Avila Lucas has nothing to disclose.
Marcelo Barriga, Sr.	Mr. Barriga has nothing to disclose.
Frank G. Solis, Sr., MD	Dr. Solis has nothing to disclose.
Aimen Vanood, MD	Dr. Vanood has nothing to disclose.
David Lanman	Mr. Lanman has received personal compensation for serving as an employee of Yoodli.
Varun Puri	Mr. Puri has stock in Yoodli.
Matthew T. Hoerth, MD, FAAN	Dr. Hoerth has a non-compensated relationship as a Epilepsy.com Editorial Board member with the Epilepsy Foundation of America that is relevant to AAN interests or activities.
Shiri Etzioni, MD	Dr. etzioni has received personal compensation for serving as an employee of mayo clinic arizona.
James B. Lewin, PharmD	Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Jose Avila-Ornelas, MD	Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
Khaled Abdalla, MD	Dr. Abdalla has nothing to disclose.
Cortnee Roman, NP, DAAN	Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. Ms. Roman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Ms. Roman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genzyme. Ms. Roman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Ms. Roman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myer Squibb/Celgene.
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Boyang Bian	Boyang Bian has received personal compensation for serving as an employee of Biogen. Boyang Bian has stock in Biogen.
Nicholas Belviso, PhD, PharmD	Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Sai L. Shankar, PhD, FAAN	Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Pranoti Pradhan	Dr. Pradhan has received personal compensation for serving as an employee of SK Life Science. Dr. Pradhan has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Pradhan has stock in Neurocrine Biosciences.
Amanda E. Fiander, MD	Dr. Fiander has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharmaceuticals. Dr. Fiander has received research support from Mitsubishi Tanabe Pharmaceuticals.
Amer A. Ghavanini, MD	Dr. Ghavanini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitisubishi Tanabe Pharm.
Dung Pham, PhD	Mr. Pham has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Canada.
Pinay Kainth	Pinay Kainth has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Canada. Pinay Kainth has received personal compensation for serving as an employee of Ultragenyx Canada.
Kristen Watkins, MD	Dr. Watkins has nothing to disclose.
Patrick Drummond, MD	Dr. Drummond has nothing to disclose.
Reya Hayek, MD	Dr. Hayek has nothing to disclose.
Christian Grommes, MD	Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Jennifer H. Newman, MD	Dr. Newman has nothing to disclose.
Lisa M. DeAngelis, MD, FAAN	Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Ingo K. Mellinghoff, MD, FACP	Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca .
Lauren Schaff, MD, FAAN	Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG, plc. The institution of Dr. Schaff has received research support from BTG, plc. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Ono.
Kerry Devlin, PhD	Dr. Devlin has nothing to disclose.
Vishank A. Shah, MD	Dr. Shah has nothing to disclose.
Rohan Mathur, MD	Dr. Mathur has nothing to disclose.
Alexander Pantelyat, MD, FAAN	Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Junaid Ansari, MD	Dr. Ansari has nothing to disclose.
Jose I. Suarez, MD, FAAN	Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.
Muna Alnamlah, MBBS	Dr. Alnamlah has nothing to disclose.
Alaa T. Hijji, MD	Dr. Hijji has nothing to disclose.
Mohamed Al Zawahman	No disclosure on file
Ashfaq Shuaib, MD	Dr. Shuaib has nothing to disclose.
Tabia Shujaat, MBBS	Dr. Shujaat has nothing to disclose.
FNU Kalpina, MBBS	Dr. Ramesh has nothing to disclose.
Javeria Javeid	Mrs. Javeid has nothing to disclose.
Dinesh Kumar	Dr. Kumar has nothing to disclose.
Aidan Keaveny	Mr. Keaveny has nothing to disclose.
Madelyn N. Ross	Ms. Ross has nothing to disclose.
Syed H. Inam, MD	Dr. Inam has nothing to disclose.
Dinesh M. Chaudhari, DNB	Dr. Chaudhari has nothing to disclose.
Pushpendra N. Renjen, MD	Dr. Renjen has nothing to disclose.
Avinash Goswami	No disclosure on file
Kamal Ahmad	No disclosure on file
Saim Amir, MBBS	Dr. Amir has nothing to disclose.
Talha A. Zia, MBBS	Mr. Zia has nothing to disclose.
Gul S. Ghouri, MBBS	Dr. Ghouri has nothing to disclose.
Zain Tariq, MBBS	Mr. Tariq has nothing to disclose.
Aanusha Ghouri, MBBS	Ms. Ghouri has nothing to disclose.
Michelle You	Ms. You has nothing to disclose.
Chase Goldberg, MD, Medical Student	Mr. Goldberg has nothing to disclose.
Michael A. Vazquez	Mr. Vazquez has nothing to disclose.
Dhruba Podder	Mr. Podder has nothing to disclose.
Rahim Hirani, MD/PhD candidate	Mr. Hirani has nothing to disclose.
Mill Etienne, MD, MPH, FAAN	Dr. Etienne has nothing to disclose.
Kunal Malik, MD	Dr. Malik has nothing to disclose.
Jenny Linnoila, MD, PhD	Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program.
Cori Polonski, MD	Dr. Polonski has nothing to disclose.
Taylor Williams, MD	Miss Williams has nothing to disclose.
Elias Granadillo, MD	Dr. Granadillo has nothing to disclose.
Abigail K. Peterson	Miss Peterson has received research support from NIH .
Laura Hancock, PhD	Dr. Hancock has received personal compensation in the range of $5,000-$9,999 for serving as a educator with Can Do MS (non-profit).
Priyanka P. Shah-Basak, PhD	The institution of Dr. Shah-Basak has received research support from NIH NIDCD. The institution of Dr. Shah-Basak has received research support from NIH NIDCD.
Sara Pillay, PhD	Dr. Pillay has nothing to disclose.
Peter Kraegel, MA	Mr. Kraegel has nothing to disclose.
Shelby Schold	Ms. Schold has nothing to disclose.
Ozioma Okonkwo, PhD	Prof. Okonkwo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for INS. The institution of Prof. Okonkwo has received research support from NIH.
Veena A. Nair, PhD	The institution of Dr. Nair has received research support from NIH.
Vivek Prabhakaran, MD	Dr. Prabhakaran has nothing to disclose.
Hrissanthi Ikonomidou, MD, PhD	An immediate family member of Dr. Ikonomidou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for RNN Journal. An immediate family member of Dr. Ikonomidou has stock in Solvay. Dr. Ikonomidou has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH, FDA.
Yi Rang Han, PhD	Dr. Han has received personal compensation for serving as an employee of AbbVie.
Anna Jeong, MD	Dr. Jeong has received personal compensation for serving as an employee of AbbVie. An immediate family member of Dr. Jeong has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Stryker. Dr. Jeong has stock in AbbVie.
Mallika Gopalkrishnan, MBBS	Dr. Gopalkrishnan has nothing to disclose.
Nidhi Chaudhary, MBBS	Dr. Chaudhary has nothing to disclose.
Shaofei Zhao	Dr. Zhao has received personal compensation for serving as an employee of AbbVie. Dr. Zhao has stock in AbbVie.
Raaidah Saari-Nordhaus	Mrs. Saari-Nordhaus has nothing to disclose.
Matthew Rosebraugh, PhD	Dr. Rosebraugh has received personal compensation for serving as an employee of AbbVie Inc. Dr. Rosebraugh has stock in AbbVie Inc..
Bill Cho, MD, PhD	Dr. Cho has received personal compensation for serving as an employee of Calico. Dr. Cho has stock in Roche.
Jessica Ye, MD, PhD	The institution of Dr. Ye has received research support from National Institutes of Health.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Negar Molazadeh, MD	The institution of Dr. Molazadeh has received research support from Genentech, Inc..
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Yasar T. Esengul, MD	Dr. Esengul has nothing to disclose.
Kimberly A. Cole, PhD, NP	Ms. Cole has nothing to disclose.
Richard E. Burgess, MD, PhD	Dr. Burgess has nothing to disclose.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Zainab Zahra, MD	Dr. Zahra has nothing to disclose.
Nyle Almeida, MD	Dr. Almeida has nothing to disclose.
Toluwanimi A. Shaanu, MBBS	Dr. Shaanu has nothing to disclose.
Hassan Imtiaz, MD	Dr. Imtiaz has nothing to disclose.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Melanie Li, MD	Dr. Li has nothing to disclose.
Michael McAree, DO	Dr. McAree has nothing to disclose.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician ��ɫ�� Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Ting Zhou, MD	Dr. Zhou has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Ana Leticia Fornari Caprara, MD	Dr. Fornari Caprara has nothing to disclose.
Vishnu V. Byroju, MD	Dr. Byroju has nothing to disclose.
Melissa Mizerik, DO	Dr. Mizerik has nothing to disclose.
Lin Yao, MD, PhD	Dr. Yao has nothing to disclose.
Manasa Sudheendra, MBBS	Dr. Sudheendra has nothing to disclose.
Rima El Atrache, MD	Dr. El Atrache has nothing to disclose.
Daniel Davila-Williams, MD	Dr. Davila-Williams has nothing to disclose.
Sarah R. Risen, MD	Dr. Risen has nothing to disclose.
Jack Wright	Jack Wright has received personal compensation for serving as an employee of Adelphi Real World.
Nathan M. Ball, BSc	Mr. Ball has nothing to disclose.
Halima Iqbal	Miss Iqbal has nothing to disclose.
Ciara Ringland	Miss Ringland has nothing to disclose.
Jeffrey B. Ratliff, MD, FAAN	Dr. Ratliff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for the journal Neurology. The institution of Dr. Ratliff has received research support from Scion NeuroStim, LLC.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Nicole M. Calautti, MD	Dr. Calautti has nothing to disclose.
Regina Kurapova, MD	Ms. Kurapova has nothing to disclose.
Helen Hernandez Lage, MD	Mrs. Hernandez Lage has nothing to disclose.
Patricia Jokl Graese, MD	Dr. Graese has nothing to disclose.
Sara M. Schaefer, MD, FAAN	Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. The institution of Dr. Schaefer has received research support from American Parkinson Disease Association. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a RITE Section Lead with ��ɫ��. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as a QOD Question Writer with ��ɫ��.
William A. Dalrymple, MD	Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REACH. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for M3. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Boxer Capital. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Capvision. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Cencora. Dr. Dalrymple has received personal compensation in the range of $0-$499 for serving as a Consultant for Lumanity. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dalrymple has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Huntington Study Group. The institution of Dr. Dalrymple has received research support from Huntington's Disease Society of America.
Courtney Seebadri-White, MD	Dr. Seebadri-White has nothing to disclose.
Andres Fernandez, MD	Dr. Fernandez has nothing to disclose.
Rasika R. Viswanathan, MD	Ms. Viswanathan has nothing to disclose.
Uzoma E. Wamuo	Mr. Wamuo has nothing to disclose.
Michelle Maynard, PharmD	Dr. Maynard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Maynard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Maynard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Sam Hooshmand, DO	Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen . The institution of Dr. Hooshmand has received research support from Novartis .
Khaled Alhwaishel, MBBS	Mr. Alhwaishel has nothing to disclose.
Aisha Rizwan Ahmed, MBBS	Dr. Rizwan Ahmed has nothing to disclose.
Jhon E. Bocanegra-Becerra	Mr. Bocanegra-Becerra has nothing to disclose.
Mariano Gallo Ruelas, RD	Mr. Gallo Ruelas has nothing to disclose.
David Medina Julio, MD	Dr. Medina Julio has received research support from CONAHCYT.
Andrea Nuñez de Caceres Garcia, MD	Miss Nuñez de Caceres Garcia has received research support from Secretaría de Salud.
Carlos Cantu, MD, MSc	Dr. Cantu has nothing to disclose.
Ximena A. García-Velazquez	Miss García-Velazquez has nothing to disclose.
Osmar F. Albores, MD	Dr. Albores has nothing to disclose.
Ahmed Raza	Ahmed Raza has nothing to disclose.
Fizza Tariq, MD	Dr. Tariq has nothing to disclose.
Mohammad Munim Zahoor, MD	Mr. Zahoor has nothing to disclose.
Umair Ahmed, MD	Dr. Ahmed has nothing to disclose.
Mehwish Khan, DO	Dr. Khan has nothing to disclose.
Borja Izaguirre Casero, DO	Dr. Izaguirre Casero has nothing to disclose.
Siddharth Dalal, MD	Dr. Dalal has nothing to disclose.
Edward Yu, MD, FAAN	Dr. Yu has nothing to disclose.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Sophia Perrotta, Medical Student	Miss Perrotta has nothing to disclose.
Daniel Monzo	Mr. Monzo has nothing to disclose.
Matthew Shelly, BS	Mr. Shelly has nothing to disclose.
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Danielle A. Becker, MD	Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Randa G. Jarrar, MD	Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
Tracy A. Glauser, MD	Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. The institution of Dr. Glauser has received research support from NIH. Dr. Glauser has received intellectual property interests from a discovery or technology relating to health care. Dr. Glauser has received publishing royalties from a publication relating to health care.
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Evelyn K. Shih, MD, PhD	Dr. Shih has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Shih has received personal compensation for serving as an employee of SK Life Science, Inc.
Adrian L. Rabinowicz, MD, FAAN	Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.
Barbara Antonia D. Talah, Medical Student	Miss Talah has nothing to disclose.
Julia Mello, Student	Mrs. Mello has nothing to disclose.
Hamilton Roberto Moreira de Oliveira Carrico	Mr. Roberto Moreira de Oliveira Carrico has nothing to disclose.
Paulo M. Cruz, Sr., Student	Mr. Cruz has nothing to disclose.
Giovanna Pontirolli	Miss Pontirolli has nothing to disclose.
Nuris M. Torres Argota, Sr.	Dr. Torres Argota has nothing to disclose.
Manuela B. Teles	Miss Teles has nothing to disclose.
Larissa E. Tanimoto, student	Miss Tanimoto has nothing to disclose.
Riona Anvekar	Miss Anvekar has nothing to disclose.
Ananya N. Kattela	Ms. Kattela has nothing to disclose.
Miriam Quinlan, MD, MPH	Dr. Quinlan has nothing to disclose.
Karishma A. Popli, MD, MBE	Dr. Popli has nothing to disclose.
Marie S. Depew, NP	Mrs. Depew has nothing to disclose.
Cole Sterling, MD	Dr. Sterling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Sterling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medical Logix. Dr. Sterling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Haymarket Medical ��ɫ��. Dr. Sterling has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acrotech Biopharma.
Paul A. Nyquist, MD, MPH, FAAN	Dr. Nyquist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for astra Zenneca. The institution of Dr. Nyquist has received research support from NIH.
Cay Anderson-Hanley, PhD	Prof. Anderson-Hanley has received personal compensation for serving as an employee of iPACES LLC. Prof. Anderson-Hanley has stock in iPACES LLC. The institution of Prof. Anderson-Hanley has received research support from NIA. The institution of Prof. Anderson-Hanley has received research support from NINDS. Prof. Anderson-Hanley has received intellectual property interests from a discovery or technology relating to health care.
Paul Arciero, PhD	Dr. Arciero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Isagenix International LLC . Dr. Arciero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Isagenix International LLC . Dr. Arciero has received research support from NIH NIA and NINDS. Dr. Arciero has received publishing royalties from a publication relating to health care.
Stella Panos, PhD	Dr. Panos has nothing to disclose.
David Merrill, MD, PhD	Dr. Merrill has nothing to disclose.
Emilie Saulnier, PhD	Dr. Saulnier has received personal compensation for serving as an employee of iPACES. Dr. Saulnier has stock in iPaces. Dr. Saulnier has stock in 1st Playable Productions. The institution of Dr. Saulnier has received research support from NIH.
John P. Arciero, Project Director	Mr. Arciero has received personal compensation for serving as an employee of iPACES LLC. Mr. Arciero has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for iPACES LLC. Mr. Arciero has stock in iPACES LLC. The institution of Mr. Arciero has received research support from iPACES LLC. Mr. Arciero has received intellectual property interests from a discovery or technology relating to health care. Mr. Arciero has received personal compensation in the range of $50,000-$99,999 for serving as a Project Director & COO with iPACES LLC.
Valerie Needham, PsyD	Dr. Needham has received personal compensation for serving as an employee of iPACES.
Earl A. Zimmerman, MD, FAAN	No disclosure on file
Arnaud Batchou, DO	Dr. Batchou has nothing to disclose.
James M. San Miguel, DO	Dr. San Miguel has nothing to disclose.
Nadia Irfan, MD	Dr. Irfan has nothing to disclose.
Michelle Ganat, MD	Dr. Ganat has nothing to disclose.
Kush Sharma, MBBS	Dr. Sharma has nothing to disclose.
Oleg Otlivanchik, MD	Dr. Otlivanchik has nothing to disclose.
Genaro E. Herrera Cano	Mr. Herrera Cano has nothing to disclose.
Alia Tewari, MD	Dr. Tewari has nothing to disclose.
Syed D. Asad, MD	Dr. Asad has nothing to disclose.
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Mustafa Al Gburi, MD	Dr. Al Gburi has nothing to disclose.
Idanis Berrios Morales, MD	Dr. Berrios Morales has nothing to disclose.
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Roberto Bomprezzi, MD, FAAN	Dr. Bomprezzi has nothing to disclose.
Julia Huck, PhD	Ms. Huck has received research support from Fonds de. recherche du Québec – Nature et technologie (FRQNT).
Mathilde Langlois, BSc	Miss Langlois has nothing to disclose.
Samantha Cote, PhD	Ms. Cote has nothing to disclose.
Monica Sean, MSc	The institution of Ms. Sean has received research support from Canadian Institutes of Health Research.
Vincent Doyon	Mr. Doyon has received research support from Fonds de recherche du Québec - Nature et technologie.
Kevin Whittingstall, PhD	Prof. Whittingstall has nothing to disclose.
Benjamin D. Sacks, MBBS	Dr. Sacks has nothing to disclose.
Balwindar Athwal, MBBS	Dr. Athwal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Marcos Vinicius Oliveira Marques, MD	Marcos Vinicius Oliveira Marques, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC therapeutics.
Edmar Zanoteli	Edmar Zanoteli has nothing to disclose.
Thiago Y. Silva, MD	Dr. Silva has nothing to disclose.
Jose Luiz Pedroso, MD	Dr. Pedroso has nothing to disclose.
Orlando G. Barsottini, MD, PhD	Dr. Barsottini has nothing to disclose.
Jaber H. Jaradat, MD	Dr. Jaradat has nothing to disclose.
monther n. ramadan, MD	Mr. ramadan has nothing to disclose.
Yousof Al-Bojoq, Sr., PhD	Dr. Al-Bojoq has nothing to disclose.
Abdulqadir Nashwan	Abdulqadir Nashwan has nothing to disclose.
Axel C. Reyes	Mr. Reyes has nothing to disclose.
Moisés Rojas Doroteo	Mr. Rojas Doroteo has nothing to disclose.
Heidy V. Tejeda Santana, Jr., MS	Miss Tejeda Santana has nothing to disclose.
Angel Carreras, MD	Dr. Carreras has nothing to disclose.
Susan Criswell, MD	Dr. Criswell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie.
Susan Nielsen	The institution of Susan Nielsen has received research support from National Institutes of Health. The institution of Susan Nielsen has received research support from Department of Defense. The institution of Susan Nielsen has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Susan Nielsen has received research support from Cure Alzheimer's. Susan Nielsen has received personal compensation in the range of $0-$499 for serving as a Panel/committee member with The Michael J. Fox Foundation for Parkinson's Research. Susan Nielsen has received personal compensation in the range of $0-$499 for serving as a Reviewer with Parkinson's Disease Foundation.
Kassu Mehari Beyene, PhD	Dr. Beyene has nothing to disclose.
ALEJANDRA CAMACHOSOTO, MD	The institution of Dr. CAMACHOSOTO has received research support from Michael J Fox Foundation . The institution of Dr. CAMACHOSOTO has received research support from NIH NCATS KL2 Career Development.
Alexandru Lerint, MD	Dr. Lerint has nothing to disclose.
Oreoluwa E. Morakinyo, MBBS	Dr. Morakinyo has nothing to disclose.
Fnu Komal, MD, MBBS	Dr. Komal has nothing to disclose.
Johanna S. Canenguez, MD	Dr. Canenguez has nothing to disclose.
Stéphane Auvin, MD, PhD	Prof. Auvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grintherapeutics. The institution of Prof. Auvin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia.
J. Helen Cross	Dr. Cross has nothing to disclose.
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Scott Perry	No disclosure on file
Rocio Sanchez-Carpintero	No disclosure on file
Nicola Specchio	Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for stoke.
Adam Strzelczyk	Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bicodex. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UNEEG.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Ankush Maheshwary, MBBS	Dr. Maheshwary has nothing to disclose.
Neha Prakash, MD	The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Sarah Anderson	Miss Anderson has nothing to disclose.
Juan Joaquín Bermejillo Barrera, MD	Dr. Bermejillo Barrera has nothing to disclose.
Blanca Gomez Gozalvez	Miss Gomez Gozalvez has nothing to disclose.
Juan M. Fajardo Sanchís, Jr., MD	Dr. Fajardo Sanchís has nothing to disclose.
David V. Mena, Sr.	Dr. Mena has nothing to disclose.
María Ruiz Perelló, MD	Dr. Ruiz Perelló has nothing to disclose.
Francisco Jose Salazar Hernandez	Dr. Salazar Hernandez has nothing to disclose.
CARMEN G. GARCIA, Sr., NP	Dr. GARCIA has nothing to disclose.
Ester Carreon Guarnizo	Ester Carreon Guarnizo has nothing to disclose.
Jose Antonio Perez Vicente, MD	Jose Antonio Perez Vicente, MD has nothing to disclose.
Carolina Matté Dagostini	Miss Matté Dagostini has nothing to disclose.
Juan S. Sánchez León, Sr., MD	Dr. Sánchez León has nothing to disclose.
Renato Dumbá D. de Castro, Sr., MD	Mr. de Castro has nothing to disclose.
Fernanda Broch, MD	Miss Cínica has nothing to disclose.
Pedro H. Ruschel, MD	Mrs. Ruschel has nothing to disclose.
KARLA S. SANDOVAL CASTRO, MD	Dr. SANDOVAL CASTRO has nothing to disclose.
TAIS L. DENICOL, MD	Miss DENICOL has nothing to disclose.
Shane Fuentes, MD	Dr. Fuentes has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Haia Hazim, DO	Dr. Hazim has nothing to disclose.
Sathvik S. Shastry, MD	Dr. Shastry has nothing to disclose.
Nathan P. Fenstermacher	Mr. Fenstermacher has nothing to disclose.
Christopher Melinosky, MD	Dr. Melinosky has nothing to disclose.
Megan C. Leary, MD	Dr. Leary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Clinical Research Institute. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Baim Clinical Research Institute. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Leary has received publishing royalties from a publication relating to health care.
Anderson S. Corin	Mr. Corin has nothing to disclose.
Gabriel Semione, Medical Student	Mr. Semione has nothing to disclose.
Isabela Z. Leal II, Medical student	Miss Leal has nothing to disclose.
Lidia Cheidde, Medical Student	Miss Cheidde has nothing to disclose.
Luiz Guilherme S. Almeida	Mr. Almeida has nothing to disclose.
Matheus D. Pereira, MD	Dr. Pereira has nothing to disclose.
Jamie Harris, BS	Ms. Harris has nothing to disclose.
Hope Hua, MD	Dr. Hua has nothing to disclose.
Kinjal Thakor, MD	Dr. Thakor has nothing to disclose.
Mohammad Ammar Ur Rahman, MBBS	Dr. Ammar Ur Rahman has nothing to disclose.
Luqman Munir	Mr. Munir has nothing to disclose.
Sagar Vaidya, MD, PhD	Dr. Vaidya has received personal compensation for serving as an employee of Cerevance. Dr. Vaidya has received intellectual property interests from a discovery or technology relating to health care.
Nicola Brice, PhD	Dr. Brice has received personal compensation for serving as an employee of Cerevance.
Louise Dickson, PhD	Dr. Dickson has received personal compensation for serving as an employee of Cerevance.
Roberto Tolando, PhD	Dr. Tolando has nothing to disclose.
Celina Scholl, Doctor of Physical Therapy	Dr. Scholl has nothing to disclose.
Michelle Charles, MPH	Mrs. Charles has received personal compensation for serving as an employee of Cerevance Inc..
Bernardino Ossola, PhD	Dr. Ossola has received personal compensation for serving as an employee of Cervance.
Graham Scott, PhD	Dr. Scott has received personal compensation for serving as an employee of GS Drug Development Sciences Ltd. An immediate family member of Dr. Scott has received personal compensation for serving as an employee of GS Drug Development Sciences Ltd.
Martin Bexon, MBBS	Dr. Bexon has received personal compensation for serving as an employee of BexonClinical Consulting LLC.
Lee Dawson, PhD	Dr. Dawson has received personal compensation for serving as an employee of Cerevance Ltd. Dr. Dawson has stock in Cerevance Ltd.
Mark Carlton, PhD	Dr. Carlton has received personal compensation for serving as an employee of Cerevance. Dr. Carlton has stock in Cerevance.
Kim Matthews	Dr. Matthews has nothing to disclose.
Jesminne Castricum, PhD	Miss Castricum has nothing to disclose.
Philip Kremer, MD, PhD	Dr. Kremer has received personal compensation for serving as an employee of Foundation The Centre for Human Drug Research.
Tomasz Chmiela, MD	Dr. Chmiela has nothing to disclose.
Jaroslaw Dulski, MD, PhD	Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange. Dr. Dulski has received intellectual property interests from a discovery or technology relating to health care.
Erik Middlebrooks	Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Corp. Erik Middlebrooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Siemens Healthineers. Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Neuroradiology.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Sadeen Eid	Sadeen Eid has nothing to disclose.
Mohammed S. Alhallaq, Sr., MD	Dr. Alhallaq has nothing to disclose.
Hamza K. Alsalhi	Dr. Alsalhi has nothing to disclose.
Yusra Arafeh, MD	Dr. Arafeh has nothing to disclose.
Muhammad Idrees, MBBS	Dr. Idrees has nothing to disclose.
Ahmed Negida, MD, PhD	Dr. Negida has nothing to disclose.
Zeid Qudeimat	Mr. Qudeimat has nothing to disclose.
Katherine Hernandez	Miss Hernandez has nothing to disclose.
Safia Sharif	Miss Sharif has nothing to disclose.
Nathan Jones	Mr. Jones has nothing to disclose.
sterling ortega, PhD	Dr. ortega has nothing to disclose.
Jason Lerner, MD	Dr. Lerner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Lerner has or had stock in Biohaven Pharmaceuticals.
David Stock	David Stock has nothing to disclose.
Michael E. Bozik, MD	Dr. Bozik has received personal compensation for serving as an employee of Biohaven . Dr. Bozik has stock in Biohaven.
Vivian M. Suarez, MD	Dr. Suarez has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Lia Donahue	Lia Donahue has nothing to disclose.
Michelle DeGrosky	Ms. DeGrosky has nothing to disclose.
Nick Kozauer	Dr. Kozauer has received personal compensation for serving as an employee of Biohaven. Dr. Kozauer has stock in Biohaven.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Sadia Nishat, MBBS, FCPS Neurology	Dr. Nishat has nothing to disclose.
Mughis Sheerani, MD	Dr. Sheerani has nothing to disclose.
Jonathan C. Calkwood, MD	Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bio. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Calkwood has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Calkwood has received research support from Sanofi. The institution of Dr. Calkwood has received research support from Novartis. The institution of Dr. Calkwood has received research support from Astra Zenica. The institution of Dr. Calkwood has received research support from TG Therapeutics. Dr. Calkwood has a non-compensated relationship as a Board of Trustees with National MS Society that is relevant to AAN interests or activities.
Jeffrey B. English, MD	Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen idec. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for genentech. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi genzyme. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen idec. Dr. English has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genzyme. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for genentech. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therpeutics. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. English has received intellectual property interests from a discovery or technology relating to health care.
Harry Lay, NP	Mr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD/Serono. Mr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Lay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Daniel Long, DO	Dr. Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genetech. Dr. Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Long has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen . Dr. Long has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for EMD.
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Thomas J. Shoemaker, MD	Dr. Shoemaker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Shoemaker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AMGEN. Dr. Shoemaker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono.
Lana Zhovtis Ryerson, MD, FAAN	Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Sarah England, PhD	Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
Danette J. Rutledge, PhD	Ms. Rutledge has received personal compensation for serving as an employee of Biogen. Ms. Rutledge has stock in Biogen.
Hannah Padilla	Miss Padilla has nothing to disclose.
Kim Griffin, MD	Dr. Griffin has nothing to disclose.
Derek Johnson, MD	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix.
Reece Hass, DO	Dr. Hass has nothing to disclose.
Tony Zhang, MBChB	Dr. Zhang has nothing to disclose.
Ivan D. Carabenciov, MD	Dr. Carabenciov has nothing to disclose.
Rafid Mustafa, MD	Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Mustafa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PicnicHealth. Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Mustafa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon Biosciences.
Michel Toledano, MD	Dr. Toledano has nothing to disclose.
Leonardo Pipek, MD	Dr. Pipek has nothing to disclose.
Rafaela Farias Vidigal Nascimento, MD	Miss Nascimento has nothing to disclose.
Guilherme Diogo Silva	No disclosure on file
Giovanna Salema Pascual	Miss Salema Pascual has nothing to disclose.
Luiz H. Castro, MD	Dr. Castro has nothing to disclose.
Mercedes Prudencio, PhD	Prof. Prudencio has received research support from Novoglia.
Leonard Petrucelli, PhD	Dr. Petrucelli has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Expansion Therapeutics. Dr. Petrucelli has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Science Translational Medicine. The institution of Dr. Petrucelli has received research support from Novoglia. The institution of Dr. Petrucelli has received research support from Biogen. Dr. Petrucelli has received intellectual property interests from a discovery or technology relating to health care. Dr. Petrucelli has received intellectual property interests from a discovery or technology relating to health care.
Javier Rodriguez	Mr. Rodriguez has nothing to disclose.
Lara Zimmermann, MD	Dr. Zimmermann has nothing to disclose.
Ryan M. Martin, MD	Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Spinelli, Donald, & Nott. The institution of Dr. Martin has received research support from CDMRP.
Krupa Savalia, MD	Dr. Savalia has nothing to disclose.
Anh P. Nguyen, MD	Dr. Nguyen has nothing to disclose.
Han Lee	An immediate family member of Han Lee has stock in Gilead.
Joseph Shen, MD, PhD	Dr. Shen has nothing to disclose.
Robyn Stoianovici, PharmD	Dr. Stoianovici has nothing to disclose.
Michael R. Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice.
Tiffany Hu, MD	Dr. Hu has nothing to disclose.
Jeffrey M. Gelfand, MD, MS, FAAN	Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Jeffrey R. Vitt, MD	Dr. Vitt has nothing to disclose.
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Gabriel Pardo, MD, FAAN	Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Pardo has or had stock in Progentec Diagnostics.Dr. Pardo has or had stock in Cadenza Bio.
Scott S. Zamvil, MD, PhD, FAAN	Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Ibolya Boer, MD	Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Alit Bhatt	Alit Bhatt has nothing to disclose.
Min Wu, PhD	Dr. Wu has nothing to disclose.
Xixi Hu	Xixi Hu has received personal compensation for serving as an employee of Novartis. Xixi Hu has stock in Novartis.
Valentine Jehl	Valentine Jehl has received personal compensation for serving as an employee of Novartis Pharma AG. Valentine Jehl has stock in Novartis. Pharma AG.
Roseanne Sullivan	Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Khadija Alam	Khadija Alam has nothing to disclose.
Anum Touseef Hussain, MBBS	Ms. Hussain has nothing to disclose.
Mahek Kataria	Miss Kataria has nothing to disclose.
Tooba Marriam, MD	Ms. Marriam has nothing to disclose.
Faraz Arshad	Mr. Arshad has nothing to disclose.
Amna K. Ahmed, Student	Miss Ahmed has nothing to disclose.
TOOBA HUSSAIN, MD	Dr. HUSSAIN has nothing to disclose.
syeda zil e zehra naqvi, MBBS	Mrs. naqvi has nothing to disclose.
Rafia Imran, MBBS	Dr. Imran has nothing to disclose.
Fatima Mansoor, MBBS	Miss Mansoor has nothing to disclose.
Muhammad O. Bhatti	Mr. Bhatti has nothing to disclose.
Sabah Arif, MBBS	Miss Arif has nothing to disclose.
Fatima Kaleem Ahmed, MBBS	Ms. AHMED has nothing to disclose.
Abdul Qahar K. Yasinzai, MBBS	Dr. Yasinzai has nothing to disclose.
Syed Sarmad Javaid, MBBS	Dr. Javaid has nothing to disclose.
Arkady Nisman, PharmD	Dr. Nisman has received personal compensation for serving as an employee of SK Life Science, Inc.. Dr. Nisman has a non-compensated relationship as a Senior Director, Medical Affairs with SK Life Science, Inc. that is relevant to AAN interests or activities.
Ian Rankine, DO	Dr. Rankine has nothing to disclose.
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Kristin Salottolo, MPH	Ms. Salottolo has nothing to disclose.
Katie Higgins, MD	Dr. Higgins has nothing to disclose.
Anna Belits, DO	Dr. Belits has nothing to disclose.
Frank Wang, DO	Dr. Wang has nothing to disclose.
DaYoung Kim, DO	Dr. Kim has nothing to disclose.
Yasaman Pirahanchi, MD	Dr. Pirahanchi has nothing to disclose.
Christian J. Burrell, MD	Dr. Burrell has nothing to disclose.
Yoon J. Choi, MD	Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks.
Xiao-Tang Kong, MD, PhD	Dr. Kong has nothing to disclose.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
Philippe-Antoine Bilodeau, MD	Dr. Bilodeau has nothing to disclose.
Anastasia Vishnevetsky, MD	The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Monique Anderson, MD, PhD	Dr. Anderson has nothing to disclose.
Rebecca Salky	Rebecca Salky has nothing to disclose.
Gabriela Romanow	Gabriela Romanow has nothing to disclose.
Takahisa Mikami, MD	Dr. Mikami has nothing to disclose.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
KEVIN ROYCE ANG, MD, RN	Dr. ANG has nothing to disclose.
Dan Neftalie A. Juangco, MD	Dr. Juangco has nothing to disclose.
Naomi R. Kass	Ms. Kass has nothing to disclose.
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Haleigh D. Stafford	Ms. Stafford has nothing to disclose.
Graham A. McLeod, MD	Dr. McLeod has nothing to disclose.
Aravind Ganesh, MD	Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as a Consultant for Figure 1. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Canada. Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ganesh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Ganesh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Let's Get Proof (Collavidence Inc). Dr. Ganesh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� (journals Neurology and Neurology: Clinical Practice). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association (journal: Stroke). Dr. Ganesh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers (for Frontiers in Neurology). Dr. Ganesh has or had stock in SnapDx.Dr. Ganesh has or had stock in Collavidence Inc.Dr. Ganesh has or had stock in DataSimpl. The institution of Dr. Ganesh has received research support from Canadian Institutes of Health Research . The institution of Dr. Ganesh has received research support from Alberta Innovates. The institution of Dr. Ganesh has received research support from University of Calgary Centre for Clinical Research. The institution of Dr. Ganesh has received research support from Innovation 4 Health. The institution of Dr. Ganesh has received research support from Government of Canada INOVAIT. The institution of Dr. Ganesh has received research support from Campus Alberta Neuroscience. The institution of Dr. Ganesh has received research support from Alzheimer Society of Canada. The institution of Dr. Ganesh has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Ganesh has received research support from New Frontiers in Research Fund. The institution of Dr. Ganesh has received research support from Panmure House. The institution of Dr. Ganesh has received research support from Brain Canada. The institution of Dr. Ganesh has received research support from MSI Foundation. The institution of Dr. Ganesh has received research support from France Canada Research Fund. Dr. Ganesh has received intellectual property interests from a discovery or technology relating to health care.
Aaron R. Switzer, MD	Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Company Limited.
Eric E. Smith, MD	Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Luca Bartolini, MD, FAAN	Dr. Bartolini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. Dr. Bartolini has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��.
Alonso Zea Vera, MD	The institution of Dr. Zea Vera has received research support from American Brain Foundation, Tourette Association of America, ��ɫ��.
Georg T. Scheffler, MD	Mr. Scheffler has nothing to disclose.
Leon D. Kaulen, MD	Dr. Kaulen has nothing to disclose.
Joachim M. Baehring, MD, FAAN	Dr. Baehring has nothing to disclose.
Purani Jayaraj	Miss Jayaraj has nothing to disclose.
Arman Sinha, Undergraduate	Mr. Sinha has nothing to disclose.
Adithya Sai Ram Gampala, Student	Mr. Gampala has nothing to disclose.
Divya D. Kamble	Miss Kamble has nothing to disclose.
Suhrud Panchawagh, MBBS	Dr. Panchawagh has nothing to disclose.
Sambhav Mathur	No disclosure on file
Kashish Padariya, MBBS	Miss Padariya has nothing to disclose.
Palash D. Shah	Mr. Shah has nothing to disclose.
Kratika Mulchandani	Ms. Mulchandani has nothing to disclose.
Rishabh Agrawal	Mr. Agrawal has nothing to disclose.
Smit R. Alurwar	Mr. Alurwar has nothing to disclose.
Mahima J. Suryawanshi, MBBS	Miss Suryawanshi has nothing to disclose.
Nora Nikprelevic, MD, MBBS	Dr. Nikprelevic has nothing to disclose.
Paunel Agyei, MD	Dr. Agyei has nothing to disclose.
Paulina Birenbaum, DO	Dr. Birenbaum has nothing to disclose.
Victor Ekuta, MD	Dr. Ekuta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Doximity. Dr. Ekuta has or had stock in Doximity.Dr. Ekuta has received research support from Rainwater Charitable Foundation. Dr. Ekuta has received research support from Cell Press, Elsevier, Cell Signaling Technologies. Dr. Ekuta has received research support from Rare Disease Diversity Coalition. Dr. Ekuta has received personal compensation in the range of $0-$499 for serving as a Contractor with ScaleAI. Dr. Ekuta has received personal compensation in the range of $500-$4,999 for serving as a Contractor with Mercor Labs. Dr. Ekuta has received personal compensation in the range of $500-$4,999 for serving as a ANA Futures Program Participant with American Neurological Association.
Davut Pehlivan, MD	Dr. Pehlivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
James R. Lupski, MD, PhD	Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Genetics Center.
Daniel Calame, MD, PhD	Dr. Calame has nothing to disclose.
Priyanka Atit, DO	Dr. Atit has nothing to disclose.
Avinash S. Kolli, MD	Dr. Kolli has nothing to disclose.
Anthony M. Bradshaw, MD	Dr. Bradshaw has nothing to disclose.
Muhammad Bilal Sardar	Dr. Sardar has nothing to disclose.
Muhammad A. Nadir, MBBS	Mr. Nadir has nothing to disclose.
ARMAGHAN UR REHMAN	ARMAGHAN UR REHMAN has nothing to disclose.
Mohsin Raza, MBBS	Dr. Raza has nothing to disclose.
Muhammad U. Khan, MD, MBBS	Dr. KHAN has nothing to disclose.
Dhruv Bansal, MBBS, MRCP UK	Dr. Bansal has nothing to disclose.
Seamus J. Kearney	Dr. Kearney has nothing to disclose.
Jia Dong James Wang	Mr. Wang has nothing to disclose.
Carol H. Tham, MBBS, MRCP	Dr. Tham has nothing to disclose.
Othman Bin Alamer	Othman Bin Alamer has nothing to disclose.
Kiran K. Sankarappan, BS	Mr. Sankarappan has received research support from Burroughs Wellcome Fund.
Kishore Balasubramanian, MS	Mr. Balasubramanian has nothing to disclose.
Abdurrahman Kharbat, MD, MBA	Dr. Kharbat has nothing to disclose.
Shana Dodge	Shana Dodge has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration (AFTD).
Jessica Shurer, MSW	Ms. Shurer has received personal compensation for serving as an employee of CurePSP.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Farwa Ali, MD	Dr. Ali has nothing to disclose.
Sarah Kremen, MD	Dr. Kremen has received publishing royalties from a publication relating to health care.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Lawren VandeVrede, MD, PhD	Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CND Life Sciences. Dr. VandeVrede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peerview CME. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Haymarket. Dr. VandeVrede has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peter Lacques, LLC. Dr. VandeVrede has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cunningham Bounds. The institution of Dr. VandeVrede has received research support from Alzheimer's Association. The institution of Dr. VandeVrede has received research support from NIH.
Cathy Wang, MSW	Ms. Wang has nothing to disclose.
Anne Marie A. Wills, MD	Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant, a CVS/Caremark company. Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi/Genzyme. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Wills has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceuticals. The institution of Dr. Wills has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Wills has received research support from Parkinson's Foundation. The institution of Dr. Wills has received research support from Biogen. The institution of Dr. Wills has received research support from Roche/Genentech. The institution of Dr. Wills has received research support from BioSensics.
Kristophe Diaz, PhD	Dr. Diaz has nothing to disclose.
Penny Dacks, PhD	Penny Dacks has received personal compensation for serving as an employee of The Association for Frontotemporal Degeneration.
Julio C. Rojas-Martinez, MD, PhD	Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.
David Acero-Garces, MD	Dr. Acero-Garces has nothing to disclose.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from ��ɫ��.
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Asli Buyukkurt, MD	Dr. Buyukkurt has nothing to disclose.
Wajeeh Hassan, MBBS	Mr. Hassan has nothing to disclose.
Muhammad Inam Ul Haq, MD, MBBS	Dr. Inam Ul Haq has nothing to disclose.
Kabeer Nangdev, MBBS	Mr. Nangdev has nothing to disclose.
Ramesh Shrestha, MD	Dr. Shrestha has nothing to disclose.
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.
Syed Zaeem Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Pulkit Sondhi, MD	Dr. Sondhi has nothing to disclose.
Jagjot Singh, MBBS	Dr. Singh has nothing to disclose.
Ramanjot Kaur, MBBS	Dr. Kaur has nothing to disclose.
Aparna Kathait	Dr. Kathait has nothing to disclose.
Akrambir S. Brar, MBBS	Dr. Brar has nothing to disclose.
Matthias Dunse, MD	Dr. Dunse has nothing to disclose.
Nancy Song, MD	Dr. Song has nothing to disclose.
Rohit Gummi, MD	Dr. Gummi has nothing to disclose.
Jaime R. Lopez, MD	An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
Nicholas Meyers, MD	Dr. Meyers has nothing to disclose.
Mark Keroles, MD	Dr. Keroles has received intellectual property interests from a discovery or technology relating to health care.
Ankita Tippur, MD	Dr. Tippur has nothing to disclose.
Sungho K. Cho, MD	Dr. Cho has nothing to disclose.
Leslie H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Felix Chang, MD	Dr. Chang has nothing to disclose.
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Viet Nguyen, MD	Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Emma A. Snyder, MS, CGC (Genetic Counselor)	Ms. Snyder has nothing to disclose.
John Sanderson, MD	Dr. Sanderson has nothing to disclose.
Thomas D. Bird, MD, FAAN	Dr. Bird has nothing to disclose.
Marie Y. Davis, MD, PhD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
Illya Tolokh, MD	Dr. Tolokh has nothing to disclose.
Ayush Patel	Mr. Patel has nothing to disclose.
Daniella Iglesias Hernández, MD	Dr. Iglesias Hernández has nothing to disclose.
Monica Ferrer, MD	Dr. Ferrer has nothing to disclose.
Claire Miller, MD, PhD	Dr. Miller has nothing to disclose.
Giulietta Riboldi, MD	The institution of Dr. Riboldi has received research support from Prevail Therapeutics.
Sonu M Y	Miss M Y has nothing to disclose.
Sanskruti V. Pawar, Mbbs student	Miss Pawar has nothing to disclose.
Snehal D. Chandak, MBBS	Miss Chandak has nothing to disclose.
Nayan H. Lakhampure, MBBS	Miss Lakhampure has nothing to disclose.
Shravya A. Kodgire, MBBS	Miss Kodgire has nothing to disclose.
Sushmita A. Pawar	Miss Pawar has nothing to disclose.
Sepideh Allahdadian, MD	Dr. Allahdadian has nothing to disclose.
Mansoureh Mamarabadi, MD	Dr. Mamarabadi has nothing to disclose.
Cyrus Cheung	Mr. Cheung has nothing to disclose.
Siddharth Selvakumar	Mr. Selvakumar has nothing to disclose.
Moosa Arif, BS	Mr. Arif has nothing to disclose.
Eric Zhao, BS	Mr. Zhao has nothing to disclose.
Chathuri S. Dodam Mullage, MBBS	Dr. Dodam Mullage has nothing to disclose.
Katherine Mackenzie, MD	Dr. Mackenzie has nothing to disclose.
Samantha Levin, MD	Ms. Levin has nothing to disclose.
Ryan D. Jacobson, MD	Dr. Jacobson has nothing to disclose.
Victoria Mazo, MD	Dr. Mazo has nothing to disclose.
Kathleen A. Murray, MD	Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint .
I-Hweii A. Chen, MD, PhD, FAAN	The institution of Dr. Chen has received research support from Healey Center at Massachusetts General Hospital. The institution of Dr. Chen has received research support from General Hospital Corporation. The institution of Dr. Chen has received research support from Argenx.
Hany Atwan	Mr. Atwan has nothing to disclose.
Merna R. Roshdy, MBBS	Dr. Roshdy has nothing to disclose.
Rahma A. Ibrahim	Ms. Ibrahim has nothing to disclose.
Shorouq Sakrana, MD	Dr. Sakrana has nothing to disclose.
Papul Chalia, MD	Dr. Chalia has nothing to disclose.
Sol T. De Jesus, MD	Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc. Dr. De Jesus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc.
Ereny Demian, MD	Dr. Demian has nothing to disclose.
Soheil El-Azzouni, MD	Dr. El-Azzouni has nothing to disclose.
Chaichana Sinthuwong, MD	Dr. Sinthuwong has nothing to disclose.
Robert D. Adams, MD	Dr. Adams has received personal compensation in the range of $100,000-$499,999 for serving as a Full time employee -Physician with Louis Stokes Cleveland VA Medical Center.
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Zheming Yu, MD	Dr. Yu has nothing to disclose.
Emily J. Hill, MD	Dr. Hill has nothing to disclose.
Unaiza Memon	Dr. Memon has nothing to disclose.
Faisal R. Jahangiri, MD, DABNM, FASNM, FASET	Prof. Jahangiri has nothing to disclose.
Sheida Koohsari, MD	Dr. Koohsari has nothing to disclose.
Luis Miguel Situ-Kcomt	No disclosure on file
Andrew J. Creed, MD	Dr. Creed has nothing to disclose.
josue avecillas, MD, PhD	Dr. avecillas has nothing to disclose.
Pietro Zara, MD	Dr. Zara has nothing to disclose.
Paola Chessa, MD	Dr. Chessa has nothing to disclose.
Giovanni A. Deiana, Sr., PhD	Dr. Deiana has nothing to disclose.
Mariangela Puci, PhD	Dr. Puci has nothing to disclose.
Giovanni Sotgiu, MD, PhD	Prof. Sotgiu has nothing to disclose.
Valentina Damato, MD, PhD	Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma.
Paolo Solla, MD	Dr. Solla has nothing to disclose.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Matheus Alves A. Silva, MD	Dr. Silva has nothing to disclose.
Amanda M. Mendonca	Miss Mendonca has nothing to disclose.
Eduardo Mesquita De Souza, MD	Dr. MESQUITA DE SOUZA has nothing to disclose.
Victor Hugo R. Marussi, Sr., MD	Dr. Marussi has nothing to disclose.
Ana luisa F. Donadon, MD	Mrs. Donadon has nothing to disclose.
Rafael B. Matias, Sr.	Mr. Matias has nothing to disclose.
Alex A. Fernandes, MD	Dr. Fernandes has nothing to disclose.
Matheus L. Munareto, MD	Mr. Munareto has nothing to disclose.
Alex Baeta	Alex Baeta has nothing to disclose.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Joshua P. Alpers, MD	Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alpers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Alpers has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Alpers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen / Johnson&Johnson.
Ashley E. Anderson, MD	Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Nicholas S. Streicher, MD	Dr. Streicher has nothing to disclose.
Ananda V. Pandurangadu, MD	Dr. Pandurangadu has received personal compensation for serving as an employee of ZS Associates.
Hari Jayaraman	Mr. Jayaraman has received personal compensation for serving as an employee of ZS Associates.
Archit Gupta, MBA	Mr. Gupta has received personal compensation for serving as an employee of ZS Associates Inc..
Nolan Campbell, PhD	Dr. Campbell has received personal compensation for serving as an employee of Johnson and Johnson.
Zia U. Choudhry, MD, PhD	Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Tarek Elshourbagy, MD	Dr. Elshourbagy has nothing to disclose.
Timothy J. Harrigan	Mr. Harrigan has nothing to disclose.
James R. Brasic, MD, FAAN	Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Image Guided Therapy Research Institute. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One World, Inc.. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Society of Nuclear Medicine and Molecular Imaging. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multidisciplinary Digital Publishing Institute. Dr. Brasic has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Gerson Lehman Group, Inc..
Erin McCoy, MD	Dr. McCoy has nothing to disclose.
Arpita Lakhotia, MD, FAAN	Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Amanda Rogers, MD	An immediate family member of Dr. Rogers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medpace.
Natalie Batta, MD	Dr. Batta has received personal compensation for serving as an employee of Avadel.
Emilie Bloyer, BS	Miss Bloyer has nothing to disclose.
Rachel Walsh, MD	Dr. Walsh has nothing to disclose.
Brian L. Appavu, MD	Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Derek Neilson	Derek Neilson has nothing to disclose.
April Sharp, MD	Dr. Sharp has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Shay and Associates, LLC. Dr. Sharp has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Germer Beaman & Brown PLLC.
Hannah Edelman, MD, PhD	Dr. Edelman has nothing to disclose.
Scott I. Otallah, MD	Dr. Otallah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck.
Alexandra Morgan	Mrs. Morgan has nothing to disclose.
Aniela Grzezulkowska, MD	Dr. Grzezulkowska has nothing to disclose.
John A. Nguyen	Mr. Nguyen has nothing to disclose.
Lekha M. Rao, MD	Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sutton Pierce. Dr. Rao has stock in Epygenix, Inc. The institution of Dr. Rao has received research support from UCB. The institution of Dr. Rao has received research support from Eisai.
Jessica Wharton, MD	Dr. Wharton has nothing to disclose.
Hanna Retallack, MD, PhD	No disclosure on file
Craig A. Press, MD, PhD	Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Margaret M. Wilson-Murphy, MD	Dr. Wilson-Murphy has nothing to disclose.
Elizabeth Ballinger, MD, PhD	No disclosure on file
Jasmine Knoll, MD	No disclosure on file
Shaina Hecht, MD	Shaina Hecht, MD has nothing to disclose.
Kristina Feja, MD	An immediate family member of Kristina Feja, MD has received personal compensation for serving as an employee of Johnson & Johnson. An immediate family member of Kristina Feja, MD has stock in Johnson & Johnson.
Japleen Kaur, MBBS	Dr. Kaur has nothing to disclose.
Humza Saeed, MBBS	Mr. Saeed has nothing to disclose.
Megha Joshi, MBBS	Dr. Joshi has received personal compensation for serving as an employee of Essen Healthcare. Dr. Joshi has received personal compensation for serving as an employee of CityMD. Dr. Joshi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for SGS Consulting.
Kameron Azarm, PhD	Dr. Azarm has received personal compensation for serving as an employee of UCB.
Heidi L. Henninger, MD, FAAN	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Sirajeddin Belkhair	No disclosure on file
Chad Ruoff, MD	Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . The institution of Dr. Ruoff has received research support from Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer with CME lectures .
David Plante	David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
Lauren Fife	Ms. Fife has nothing to disclose.
Michele Persico, MD	Dr. Persico has nothing to disclose.
Robert Fountaine	Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has or had stock in Pfizer, Inc.Robert Fountaine has or had stock in Viatris, Inc.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Michelle Manzo	Ms. Manzo has received personal compensation for serving as an employee of UCB Pharma. Ms. Manzo has stock in UCB Pharma.
Steven T. Whitworth, PhD	Dr. Whitworth has received personal compensation for serving as an employee of Neurelis Inc..
Shermila Pia, MD	Dr. Pia has nothing to disclose.
Nicole Naccara	Dr. Naccara has received personal compensation for serving as an employee of Abbvie . Dr. Naccara has stock in Abbvie.
Delia Mancoci, MD	Dr. Mancoci has received personal compensation for serving as an employee of Neurelis. Dr. Mancoci has received personal compensation for serving as an employee of Eisai. Dr. Mancoci has received personal compensation for serving as an employee of Lundbeck.
Haydn Herrema	Mr. Herrema has nothing to disclose.
Alejandro Salah, MD, PhD, MBA, MHA	Dr. Salah has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma.
Edwin J. Serrano, MD	Dr. Serrano has nothing to disclose.
Deborah A. Nichols, MS	Ms. Nichols has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Nichols has stock in Jazz Pharmaceuticals.

��ɫ����

��ɫ����

��ɫ��

��ɫ��